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Abstract 
The aim of the study was to explore the accessibility of antiretroviral treatment 
amongst people living with HIV and AIDS at Public Health Care Facilities in Gert-
Sibande Region in Mpumalanga. The study was conducted at a selected Public 
Health Care facility in Gert Sibande Region at Msukaligwa Municipality in 
Mpumalanga. The study focused primarily on people attending wellness 
programmes that are living with HIV and AIDS, receiving antiretroviral treatment in 
Public Health Care facilities. 
Research design of the study was exploratory which fundamentally used to explore a 
new topic or to learn more about issues where little is known. The research approach 
was purely qualitative methodology which allowed the researcher to explore deeply 
the perceptions of people living with HIV and AIDS and the capabilities in the 
provision of antiretroviral treatment at public health care facilities in Msukaligwa 
municipality of Gert-Sibande Region in Mpumalanga. Qualitative interview is the 
method that has been used to gather data from 23 participants who took part in the 
study. Questions of the interview were semi-structured in-depth one-on-one 
interviews and were used to explore understanding in relation to the accessibility of 
antiretroviral treatment amongst people living with HIV and AIDS at Public Health 
Care Facilities in Gert- Sibande Region in Mpumalanga. 
The findings of the study revealed that, there is good accessibility of antiretroviral 
treatment at public health care facilities in Msukaligwa Municipality of Gert-Sibande 
Region in Mpumalanga. There is also an existence of negative staff attitude towards 
patients and a probable poor service delivery at the referral local clinics. 
It can be concluded that there is a need to re-look into the current Hospital’s 
reception filing system and the turnaround time at certain areas of the Hospital and 
the capacitation of staff at the wellness centre. There is also a need to intensify the 
established programmes and the encouragement of people on treatment to take their 
antiretroviral treatment consistently.  
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CHAPTER ONE 
INTRODUCTION AND BACKGROUND OF THE STUDY 
 
1.1 Introduction 
This chapter entails the background of the study and it also discusses the rationale of 
the study, statement of the problem, the aim of the study, the objective of the study, 
research questions and significance of the study and definition of terms. The study 
explores the accessibility of antiretroviral treatment amongst people living with HIV and 
AIDS at Public Health Care facilities in Gert-Sibande Region in Mpumalanga. Treatment 
against Human Immunodeficiency Virus (HIV) and acquired Immunodeficiency 
Syndrome (AIDS) epidemic on a global level continues to be a challenge. HIV and AIDS 
are a serious and still an incurable disease that has become a threat to human kind. 
Therefore treatment of the HIV and AIDS is an integral part of addressing the 
challenges of living with it (UNAIDS 2014:1). 
There are various factors that contribute toward poor or good access to antiretroviral 
treatment. Those factors are; limited capacity of health systems, low and declining 
number of health professionals, high drug prices, long-term financial sustainability, 
inadequate laboratory and patient care infrastructure, poor patient follow-up and poor 
sustainability of drug supply (Poku 2005:124).  
A fundamental notable problem is the roll-out program of antiretroviral treatment which, 
according to the researcher seems somehow less effective. This study  assist in giving 
a clear explorative indication of what is the state of access to antiretroviral treatment 
amongst people living with HIV and AIDS at  Public Health Care facilities in Gert-
Sibande Region in Mpumalanga. 
This section discusses the background of the study. In this section the researcher 
defines what the study is all about and gives an outline about global perspectives 
regarding the accessibility of antiretroviral treatment. This section also discusses the 
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rationale for the study; outlines the statement of the problem. The aim, objective, 
significance and research questions of the study are also discussed. 
Terms pertaining to the study are also defined and there is also a review of the related 
literature regarding the similar studies. Research methodology of the study is also 
discussed together with the research method, research design and area of study, target 
population, sampling and sample size, research instruments for data collection and the 
process are outlined in this study. 
Methods to ensure credibility and trustworthiness of the research findings are also 
discussed The study„s piloting strategy and how a pilot study will be conducted, are also 
explained. Data analysis and the issue of ethical considerations are detailed. The 
management of HIV and AIDS is critical and the use of antiretroviral treatment is of 
fundamental importance (Gast 2010:11). 
1.2 Background of the Study 
According to statistics people living with HIV globally in 2014 were estimated at 36.9 
million and out of 36.9 million people, 25.8 million are found in the Sub-Saharan Africa. 
This shows that around 70 percent of people living with HIV reside in the Sub-Saharan 
Africa. South Africa has the biggest and most high profile HIV epidemic in the world. In 
2016 an estimated 7 million people were living with HIV, with 180,000 South Africans 
dying from AIDS-related illnesses. It is estimated that in South Africa a new infection 
rate is at 380 000. Kwazulu Natal (KZN) still led the South African provinces by 40% 
followed by Mpumalanga Province (MP) with 37.7%.  South Africa has the largest 
antiretroviral treatment roll-out program in the world. Life expectancy has also increased 
by five years since the height of the epidemic. Moreover, the efforts pertaining to 
curbing the spread of the epidemic have been largely financed from South Africa„s 
domestic resources (Avert 2014:13). 
The history of HIV and AIDS in South Africa is perhaps the most controversial one in the 
Sub-Saharan Africa. It is littered with examples of government in action and harmful 
interference, pseudoscience, and conflict between politicians, HIV and AIDS 
organizations and scientists. This is influenced largely by treatment activism; resources 
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have multiplied to address the pandemic while treatment costs have plummeted. 
However, these gains are currently threatened by intellectual property challenges to the 
availability of affordable medication; increasing criticism of HIV and AIDS funding; and a 
general pull back by donors. Recent scientific breakthroughs suggesting that treatment 
is also a highly effective form of prevention and a global activist movement in support of 
new global financing mechanisms means governments in a resource constrains 
environment should bear the brunt (Smith 2013:4). 
The effect of this slow and interrupted response is still being felt in a country that is 
currently having the world‟s largest HIV and AIDS epidemic. Though certain groups are 
more at risk of HIV transmission than others, South Africa has a serious generalized 
epidemic affecting people from all sectors of society. In most regions, including the 
World Health Organization African Region, men eligible for antiretroviral treatment 
appear to be less likely to be receiving treatment than women. This implies that a man 
seems to be ignorant in issues involving HIV and AIDS. South Africa with a high burden 
of HIV infection is potentially on the track to achieve universal access. However, South 
Africa still needs urgent major support to boost scaling up of treatment from both private 
and public sector. It is therefore crucial that social and structural barriers to HIV and 
AIDS treatment are reduced to ensure better roll-out programmes in heavily burdened 
countries (WHO 2012:07). 
This escalating prevalence figures simply imply that there is a huge demand of 
antiretroviral treatment (ART) in Africa and Sub-Saharan African countries, where South 
Africa and Mpumalanga Province are located. Whatever challenges faced by Sub-
Saharan African countries are similar in Gert-Sibande Region. The Gert-Sibande 
Region is no exception to other Sub-Saharan African countries‟ Provincial Sub-Regions 
in terms of huge demands of ARVs. 
The study focuses primarily on the one variable which is; accessibility of antiretroviral 
(ARV) treatment amongst people living with HIV and AIDS at Public Health Care 
Facilities in Msukaligwa municipality of Gert-Sibande Region in Mpumalanga. The study 
investigates the state of access to antiretroviral treatment amongst people living with 
HIV and AIDS at Public Health Care facilities in Msukaligwa municipality of Gert-
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Sibande Region in Mpumalanga. According to Ermelo regional hospital board meeting 
(2014:14) the availability of Tuberculosis (TB) and antiretroviral treatment has been as 
follows: 
First quarter 85 percent, second quarter 93 percent, third quarter 94 percent, fourth 
quarter is 93 percent with annual availability of 91 percent. This indicator shows clearly 
that there is 9 percent shortage per annum of TB and antiretroviral treatment in Ermelo 
hospital and the surrounding clinics in 2013. So it is of vital importance to establish the 
impact that the 9 percent had on people living with HIV who are inclined to access 
treatment (Ermelo Hospital Strategic Plan 2014:14). 
The study assist in giving clarity regarding the state of access to treatment amongst 
people living with HIV and AIDS in Public Health Care facilities in Msukaligwa 
municipality of Gert-Sibande Region Mpumalanga. The Ermelo Regional Hospital Board 
(2014:6) further suggests that the leading causes of death are HIV and AIDS related 
death followed by TB, hypertension and diabetes mellitus following third and fourth 
respectively (Ermelo Hospital Strategic Plan 2014:06). 
HIV and AIDS pose a serious threat to socio-economic conditions of South Africa and 
the response against the impact caused as a result, should be highly intensified. The 
researcher holds a view that there is still an alarming inadequate supply of antiretroviral 
treatment in Public Health Care facilities around South Africa and Mpumalanga 
Province. 
The important factor in selecting a problem to be studied is its significance to health and 
contributing to the body of knowledge, findings of this study are valid not only for the 
South African context, but by addressing issues that are entailed in the South Africa„s 
National Strategic Plan on HIV and AIDS. The results can be generalized to other 
countries with similar challenges. The results of this study provide baseline knowledge 
and understanding of the underlying conditions of access to antiretroviral treatment in 
Public Health Care facilities. The researcher believes that the recommendations of the 
study made to the Chief Executive Officer and Hospital Board and the District Manager 
will contribute to a solid foundation that will assist in improving challenges pertaining to 
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antiretroviral  accessibility in Public Health Care facilities in Msukaligwa Municipality of 
Gert-Sibande Region of the  Mpumalanga Province (Brink 2002:78).  
1.3 Rationale for the Study 
The researcher was employed by the South African Police Service (SAPS) as a forensic 
analyst and a safety representative who is a Non-Executive Board Member at Ermelo 
Regional Hospital. What motivated the researcher to conduct this study were the 
opinions expressed by some colleagues at the work place regarding accessibility of 
antiretroviral treatment in Public Health Care facilities in Gert-Sibande Region. Their 
opinion ranges from their direct involvement in accessing antiretroviral treatment in 
Public Health Care facilities and general challenges that they experience when 
accessing the antiretroviral treatment. 
Other colleagues‟ opinions are drawn from the experiences of their close family 
members who rely on Public Health Care facilities for the provision of antiretroviral 
treatment. This motivated the researcher to have an interest in exploring the 
experiences regarding accessibility of antiretroviral treatment in Health Care facilities in 
Msukaligwa Municipality of Gert-Sibande Region. Information released by Department 
of Health Ermelo Regional Hospital Board (2014:6) indicate that there is still a 
significant increase in deaths of people living with HIV and the researcher saw it fit to 
conduct the study to establish whether  antiretroviral treatment is easily accessible in 
the Health Care Facilities in Msukaligwa Municipality of Gert-Sibande Region. The 
empirical findings of this study will be used, to influence the Board members in meetings 
regarding the identified challenges that need attention. The researcher realised that it is 
in the best interest of the public to receive flawless provision of antiretroviral treatment 
as they are aware of the consequences of not adhering to the antiretroviral treatment 
(NSP 2012-2016:17). 
The researcher developed a keen interest in undertaking this research whereby 
government programs, especially the structural functioning of those programmes (roll-
out programmes) are examined to ensure that they produce the desired results. The 
researcher‟s previous occupation, his role at Ermelo Hospital as well as the fact that 
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HIV and AIDS is still the most formidable public health problem facing South Africa 
motivated the researcher to conduct the study. The epidemic poses a serious challenge 
to every person and is a problem that requires communities, non-governmental 
organizations, government departments and academic institutions to work in 
collaboration with each other if the disease is to be brought under control. The 
researcher is of the view that, a true partnership is important to face the challenges 
posed by HIV and AIDS (Poku 2005:16). 
1.4 Statement of the Problem 
There has been a notable poor accessibility of antiretroviral treatment in Public Health 
Care facilities in South Africa. Economic divisions also affect the manner in which 
people living with HIV and AIDS survive. The researcher holds a view that living with 
HIV in difficult economic situation has proven to be strenuous. In South Africa, HIV is 
not a disease of poor people and the economic challenges faced with financing the 
costs of living with HIV and AIDS are high. Therefore, any unemployed person who is 
infected has to rely on social grant that is paid by government and which fails to cover 
all the costs related to living with HIV and AIDS (Squire 2007:16). 
The problem identified for this study relates to the treatment programme in South 
Africa‟s Health Care facilities in relation to the roll-out programme of antiretroviral 
treatment in Mpumalanga province. The study assist in determining whether there is 
flawless accessibility of antiretroviral treatment or not. Avert (2014) indicates that the 
choice of antiretroviral treatment depend on a number of factors, including the 
availability and price of the drugs, the number of pills, the side effects of the drugs, the 
laboratory monitoring requirements and whether there are co-blister packs or fixed dose 
combinations available and moreover, the accessibility of those drugs in public domain. 
It has been indicated that Mpumalanga has just less than half a million HIV positive 
people. Around 13% of the population and one in every five adults were estimated to be 
HIV positive in 2013. The Mpumalanga epidemic is reaching maturity with new 
infections and AIDS related deaths approaching 40 000 per annum.  
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An estimated 87 000 people were in need of Antiretroviral treatment in 2013 with around 
44% having taken up treatment (Nicolay 2013:5). 
The focus is on people living with HIV and AIDS who are on wellness programmes in 
different Health Care facilities in Gert-Sibande Region. If poor access to antiretroviral 
treatment continues chances is that, people living with HIV and AIDS might develop 
resistance due to their inconsistencies in receiving antiretroviral treatment. 
According to Poku (2005:124), the issue of how best to move forward with 
comprehensive policies and programmes that aim to mitigate the social and economic 
impact of the HIV and AIDS pandemic has become a central concern for African policy 
makers. It is now increasingly clear that to achieve this objective it is essential to 
address the issue of care and support for those affected, and to increase the access of 
people living with HIV and AIDS to effective treatment. African countries or governments 
had been identified to be experiencing challenges in scaling up programmes for treating 
and caring for people living with HIV and AIDS (Ige and Quinlan 2012:2). 
The problem of inconsistent accessibility of antiretroviral treatment must be solved as it 
can have a direct impact on the lives of people living with HIV and the mission of scaling 
up treatment. 
 
1.5 Aim of the Study 
The aim of the study is to explore understanding in relation to accessibility of 
antiretroviral treatment amongst people living with HIV and AIDS at Public Health Care 
facilities in Gert-Sibande Region in Mpumalanga.  
 
1.6 Objectives of the study 
To realize the aforementioned aim of the study, the following research objectives will be 
addressed: 
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 To explore where do the patients get access to antiretroviral treatment. 
 To explore and describe how accessible are these antiretroviral treatment in 
public health care facilities. 
 To explore and describe what can be done to improve accessibility of 
antiretroviral treatment amongst people living with HIV and AIDS in Gert-Sibande 
Region of Mpumalanga. 
 To assess the capacity of Public Health Care facility in Gert-Sibande Region and 
to develop an improved program that will strengthen accessibility of antiretroviral 
treatment in Mpumalanga Province. 
 
1.7 Research Questions 
The study will answer the following questions: 
 Where do people with HIV and AIDS access antiretroviral treatment?  
 What measures can be taken to improve accessibility of antiretroviral treatment 
amongst people living with HIV and AIDS in Gert-Sibande Region of 
Mpumalanga Province? 
  What can be done to explore and improve the accessibility of antiretroviral 
treatment in a Public Health Care facility in Mpumalanga? 
 What are the capabilities of a Public Health Care facility at Gert-Sibande Region 
in the development of an improved programme that will strengthen accessibility 
of antiretroviral treatment in Mpumalanga Province? 
 
1.8 Significance of the Study 
The study aimed at benefitting people who are attending wellness programmes in public 
health care facilities, in reference to those who are living with HIV. It adds to a new body 
of knowledge. Those benefits would take place through the outcome of the study results 
which will be given to management of the Ermelo Provincial Hospital in order to improve 
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their services. The management of Ermelo Provincial Hospital can use the study results 
to make recommendations to the provincial management of the department of health 
regarding strengthening of HIV and AIDS roll-out programmes and ensuring regular 
monitoring and evaluation of such programmes. When such an initiative has been 
applied, therefore patients will receive the best quality service as far as antiretroviral 
treatment is concerned. The study might open up new pathways for further researches 
in the field of HIV and AIDS. People living with HIV‟s opinions or perceptions regarding 
the accessibility of antiretroviral treatment will be pivotal as it would be a true reflection 
of how local programmes are performing (Ermelo Hospital Strategic Plan 2014:06). 
Overall the study‟s contribution is viewed as a cornerstone for future programmes to be 
strengthened and intensified, regular monitoring and evaluation. Academic institutions 
are set to benefit from this study and other scholars who are in the field of HIV and 
AIDS are also going to gain a useful insight. Further research can also emanate from 
the findings of this study. 
The National Department of Health (NDoH) and the management of Ermelo Regional 
Hospital Board and other stakeholders will also benefit from the research findings. Both 
parties would benefit enormously from the research results by intensifying the areas that 
needs attention as far as provisioning of antiretroviral is concerned. The Department of 
Health and the Hospital management can strengthen the areas that are lacking in terms 
of overall objectives of the mission and strategic plan of the department and that of the 
Republic of South Africa. 
 
1.9 Brief Description of the Research Process 
Exploratory study was used as the research design and the qualitative research 
methodology approach was also opted. The qualitative research approach was used 
which provide insight with regard to accessibility of antiretroviral treatment amongst 
people living with HIV and AIDS at public health care facilities in Gert-Sibande Region in 
Mpumalanga. 
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Twenty three (23) participants were interviewed in the office situated next to the 
wellness Centre and each interview lasted between 10 to 36 minutes. The main 
research questions as well as probing questions in the interview guide were used to 
facilitate the interview process. 
More details are unpacked in Chapter 3. 
 
1.10 Assumptions of the Research 
The study had the following assumptions or knowledge claim: 
(a) That there is poor accessibility of antiretroviral treatment amongst people living with 
HIV and AIDS at public health care facilities in Gert-Sibande Region in Mpumalanga. 
(b)That the participants will feel comfortable to talk about their experiences about 
access to antiretroviral treatment during the interviews. 
 
1.11 Operational Definition of Key Terms 
The following operational definitions were used for the key concepts in this study: 
(a) HIV - Human Immunodeficiency virus is a virus that enters the body from outside 
and cause a deficiency to the immunity of the body„s natural ability to defend itself 
against infection and disease (Van Dyk 2008:4). 
In this study it will be appropriate that participants‟ level of knowledge and 
understanding of HIV be determined, as it will help to explain their attitudes towards 
antiretroviral treatment. 
(b) AIDS - Acquired Immune Deficiency Syndrome is a disease, caused by the Virus 
transmitted in bodily fluids, in which there is a severe loss of cellular immunity (Concise 
Oxford Dictionary 2012:22). 
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In this study it will be appropriate that participants‟ level of knowledge and 
understanding of AIDS be determined, as it would help explain their attitudes towards 
antiretroviral treatment. 
(c) Antiretroviral Treatment - refers to the medication used to suppress viral load in 
the blood system of people living with HIV, as intensely as possible for as long as 
possible by using tolerable and sustainable treatment for an indefinite period of time 
(Van Dyk 2008:4). 
In this study it will be relevant that participants‟ level of knowledge and understanding of 
antiretroviral treatment be determined, as it would help explain their attitudes towards 
adherence and access to treatment. 
(d) People Living with HIV - refers to people living with Human Immunodeficiency 
Virus.  
In this study people living with HIV referred to participants in the study, where 
knowledge and understanding of accessing treatment will be explored. 
(e) Gert-Sibande Region - refers to one of the three (3) districts of Mpumalanga 
province and it is having its seat in Ermelo, predominantly IsiZulu and SiSwati speaking 
people. 
(f) Access - refers to the right or opportunity to use something. 
In this study it will be appropriate that participants‟ right and opportunity of accessing 
treatment will be explored. 
(g) Exploration - refers to inquiring into or discuss in details (Concise Oxford Dictionary 
2012:411).  
(h) Mpumalanga Province - is formerly known as the Eastern Transvaal, is the 
province of South Africa and boarding Swaziland and Mozambique and accounting 6.5 
% of South African land. 
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In this study exploration refers to inquiring into details about people living with HIV about 
access to treatment in Gert-Sibande Public Health Care facilities. 
1.12 Summary 
This Chapter has presented the background to the study in terms of what the study 
entail. This Chapter also presented the rationale for the study and the statement of the 
problem. The aim of the study and also the objective of the study. Research questions, 
significance of the study, and definition of terms. The next chapter (Chapter 2) deals 
with the reviewing of the related literature regarding, the accessibility of antiretroviral 
treatment globally and within the Republic of South Africa. Chapter 2 also deals with the 
theoretical framework of the study and also what has already been researched about 
the related studies. 
1.13 Outline of the Dissertation 
This study will be presented in five chapters: 
Chapter 2 will contain a literature review relating to accessibility of antiretroviral 
treatment. The Chapter will also discuss other researches about the topic and the 
importance of accessing antiretroviral treatment in public health care facilities. The 
study will also focus on the state of antiretroviral treatment in South Africa and 
challenges of rolling out antiretroviral treatment within the Republic. The public health 
care facilities in South Africa will also be examined and their capacity in providing 
treatment to those who are eligible for it. 
Chapter 3 deals with the research methodology and provides details of the research 
approaches used, the nature of the in-depth personal interviews, description of 
participants as well as the method of data collection. 
Chapter 4 presents the findings and analyses of the findings from the interviews 
conducted at Ermelo Provincial Hospital according to the purpose and objectives of the 
study. 
Chapter 5 presents the conclusion and recommendations of the study. 
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CHAPTER TWO 
LITERATURE REVIEW 
 
2.1 Introduction 
This section reviews different literature regarding the accessibility of antiretroviral 
treatment and the significance of accessing such treatment to people living with HIV. A 
literature review provided an opportunity for the researcher to conduct a systematic 
review of the existing body of knowledge and research to gain an understanding of the 
research topic and its context. Like the rest of other researches, most original 
researches are seen as an extension of what has previously been learned about a 
particular topic. A review of the literature is the way we learn what‟s already known and 
not known (Babbie, 2010:506). 
2.2 Other Research on the Topic  
2.2.1 Historical overview 
The first recognized cases of AIDS occurred in the United States of America (USA) in 
1981 when a very rare form of pneumonia suddenly appeared simultaneously in several 
patients. These patients had a number of characteristics in common: they were all 
young homosexual men with compromised (damaged) immune system and caused 
diarrhea and weight loss, was identified in central Africa in heterosexual people. Initially, 
scientists and doctors were baffled because the causes and the modes of transmission 
of this new disease could not be immediately identified. Only in 1983 was it discovered 
that the disease was caused by a virus, known at that stage as lymphadenopathy-
associated virus. In May 1986 the virus causing this condition was renamed HIV 
(Human Immunodeficiency Virus). Two viruses associated with AIDS: HIV-1 and HIV-2 
(Van Dyk 2008:4). 
HIV and AIDS is still one of the world‟s most serious health and development 
challenges. There are approximately 36.9 million people currently living with HIV and 
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tens of millions of people have died of AIDS-related causes since the beginning of the 
epidemic. While new cases have been reported in all regions of the world, 70% are in 
sub-Saharan Africa. Most people living with HIV do not have access to prevention, care, 
and treatment, and there is still no cure (The Henry Kaiser Family 2015:1). 
Sub-Saharan Africa, the hardest hit region, is home to 70% of people living with HIV but 
only about 13% of the world‟s population. Most children with HIV live in this region 
(88%).Almost all of the region‟s nations have generalised HIV epidemics-that is; their 
national HIV prevalence rate is greater than 1%. In 9 countries, 10% or more of adults 
are estimated to be HIV-positive. South Africa has the highest number of people living 
with HIV in the world (7 million) (The Henry Kaiser Family 2015:2). 
There are still challenges of scaling up HIV and AIDS treatment programs in Africa 
(Poku 2005:124). The researcher argue that, despite the work of dedicated staff and the 
resources put in the health care systems, South Africa is one of those countries 
treatment is often discussed as if, it stood alone from other health and related issues. 
The strict provision of post-exposure prophylaxis to people at risk requires a special 
consideration as far as review is concerned. The researcher hold a view that, access to 
antiretroviral treatment is still a serious challenge that needs a special attention. The 
public health care system of the Republic of South Africa still provide antiretroviral 
treatment as a therapy to prevent Mother-to-Child transmission of HIV, to manage 
occupational exposure and to manage rape and sexual assault patients( Van Dyk 
2008:109). 
HIV and AIDS related service delivery in South Africa is inextricably linked to socio-
economic rights and development. Responses to HIV and AIDS have been guided by 
the constitutionally entrenched right to health as well as by the developmental mandate 
of local governments. These criteria have been challenged, however, by changing 
policies regarding HIV and AIDS, the role of the state in service provision, the way 
service users are viewed and ambiguities regarding the decentralization of health 
services. The civil society service provision has culminated in innovative methods of 
maximizing antiretroviral therapy, which have yet to engaged with and consolidated by 
various spheres of health provision(Ige and Quinlan 2012:84).  
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The South African government‟s HIV and AIDS strategy initially rejected provision of 
treatment in favor of prevention of the spread of HIV. The government saw civil society 
being „partners‟ in service delivery. Civil society organizations actually went further, 
advocating for government provision of antiretroviral treatment and even initiating 
treatment programs in different localities. Various policy documents affirmed the role of 
a civil society even after the government changed its strategy and began to create a 
public antiretroviral programme (Ige and Quinlan 2012:89). 
Ermelo is located within the Msukaligwa Sub-district Municipality in the Gert-Sibande 
Region   the Mpumalanga Province of South Africa. It has been suggested that Gert-
Sibande Region like the rest of the country faces a quadruple burden of disease 
consisting of HIV and AIDS and tuberculosis, high maternal and child mortality. It is 
further indicated in the hospital strategic plan that, like any other part of the South 
Africa, the Gert-Sibande Region health care system has been characterized by a 
fragmented and inequitable system due to the huge disparities that exist between the 
public and private health care sectors with regard to the availability of financial and 
human resources, accessibility and delivery of health services, this implies that there 
are negative effect in terms of antiretroviral treatment accessibility (Ermelo Provincial 
Hospital Strategic Plan 2014:17). 
According to Ermelo Hospital Strategic Plan (2014:20) the district health information 
system however indicates that in the Msukaligwa Sub-district, the leading cause of 
death in 2013/2014 are HIV and AIDS followed by TB, hypertension and diabetes 
mellitus. So this report suggests clearly that, HIV and AIDS still contribute greatly in the 
cause of death within Msukaligwa Sub-district. 
The study also explores the structural functionalism of the Mpumalanga Provincial 
antiretroviral roll-out programme in public health care facilities. Decoteau (2013:19) 
indicates that people in informal settlements often cannot or will not assume the 
biomedical technologies of the self-required to take antiretroviral either because of 
structural obstacles associated with squatter conditions or because the regimen 
includes a rejection of indigenous healing. Most patients in Ermelo are very 
conservative and they still rely on indigenous healing. 
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Decoteau (2013:19) further state that HIV and AIDS have radically shaken-up the 
epistemological anchors both biomedical and indigenous healing paradigms. The fact 
that the disease is incurable but treatable seriously challenges the ontological 
foundations of South Africa indigenous healing. And yet, biomedicine‟s answer, 
antiretroviral, comes with its own complications. Because of serious under resourcing, 
public clinics, and hospitals have been equipped to properly manage this epidemic, and 
so indigenous healers have taken a burden of providing the psychological and social 
support HIV and AIDS sufferers require, in addition to treating symptoms and 
opportunistic infections (Ige & Quinlan 2012:166). 
2.2.2 The theoretical framework 
According to Chirambo & Ceasar (2003:12) the health belief model is a psychological 
model that attempts to explain and predict health behaviours by focusing on the 
attitudes and beliefs of individuals. The health belief model has been developed and 
adapted to explore a variety of long and short-term health behaviour including sexual 
risk behaviours and the transmission of HIV. It has been argued by Tayler (2004:4) that 
individuals‟ perceived ability to successfully carry out a health strategy, such as using a 
condom consistently, greatly influences his/her decision and ability to enact and sustain 
a changed behaviour. 
Health belief model does not take other factors that may influence health behaviors, the 
model does not include the influence of social norms and peer influence on people‟s 
decisions regarding their health behaviour. The model emphasises the behavioural 
modification as a very important aspect in risk reduction in the fight against the scourge 
of HIV and AIDS (Manique 2004:88). 
When one tries to draw a comparison between this theory and the proposed research, 
one can confirm that people should first be aware of their susceptibility of contracting 
diseases. It is upon the overall perception of individuals towards their susceptibility of 
contracting diseases that will influence their behaviour towards such risk. Behaviour 
change requires psychological awareness of a particular danger that pose a threat to 
that individual. 
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Adherence to antiretroviral treatment for example is seen as a safer behaviour in 
delaying progression of the HIV into a fully blown AIDS in human body. If a person is 
aware that adhering to medication will bring positive changes in his state of health then 
that person is likely to adhere to antiretroviral treatment. But if a person is not well 
aware of the implication of adhering to antiretroviral treatment and the direct 
consequences of such behaviour, such person is likely to ignore the commitment of 
taking such treatment and therefore that might lead to defaulting (Van Dyk 2008:122). 
 
Defaulting is described as a failure to fulfil an obligation (Louw and Reynolds 
2010:307).The researcher perceived adherence to antiretroviral treatment as an 
obligation. It has been further argued in this theory that, key variables in this theory are 
perceived threat. It has been further indicated that perceived threat has two parts which 
is, perceived susceptibility and perceived severity of a health condition. Perceived 
susceptibility is defined as one‟s subjective perception of the risk of contracting a health 
condition. According to Manique (2004:87) perceived severity is referred to as feelings 
concerning the seriousness of contracting an illness or of leaving it untreated including 
evaluations of both medical and clinical consequences and social consequences.  
 
This indicates that people should be aware of what is going to happen when one 
contract a specific virus such as HIV and the consequences that follows the contraction 
of such a disease. In other words it is very much important for people to learn more 
about a threat, in this case HIV and the consequences of living it untreated through the 
use of antiretroviral treatment. People need to also be made aware of the social 
consequences that are brought by HIV and AIDS. For example, after losing a 
breadwinner in the family due to HIV and AIDS related death, the family particularly 
children ended up leaving school and forced to seek jobs. That can be referred to as a 
social consequence brought by an illness or HIV and AIDS. 
 
Perceived benefits according to Chirambo & Ceasar (2003:45) believed effectiveness of 
strategies designed to reduce the threat of illness perceived barriers is referred to as the 
potential negative consequence that may result from taking particular health actions, 
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including physical, psychological and financial demands. It is very important for 
individuals to have a clear understanding of the overall consequences that may result 
from a particular health action which can impact on the physical, psychological and 
financial demands. Perceived benefits had been referred to as effectiveness of 
strategies designed to reduce the threat of illness. 
Perceived barriers and cues to action referred to either bodily or environmental such as 
media publicity that motivates people to take action. It has also been mentioned that 
other variables are diverse demographic, socio-psychological and structural variables 
that affect an individual‟s perceptions and thus directly influence health related 
behaviour. Self-efficacy is referred to as the belief in being able to execute successfully 
the behaviour required to produce the desired outcome. For example using condoms 
every time an individual have sexual intercourse can protect one from contracting HIV 
(Van Dyk 2008:123). 
It has been further indicated that the health belief model has been used to explore a 
variety of health behaviour in diverse populations. 
 
2.2.3 The importance of access to antiretroviral treatment 
The researcher holds a view that, HIV remains untreatable and the only aid available is 
the suppression of the HIV. The suppression of the virus is made possible by the 
antiretroviral treatment. 
According to Van Dyk (2008:95) the HI Virus uses enzymes to replicate itself inside 
CD4 cells. Two of the most enzymes used by the virus are reverse transcriptase 
enzyme and protease enzyme. Antiretroviral treatment act by blocking the action of 
these enzymes. Antiretroviral treatment interfere with the reverse transcriptase enzyme 
prevents the virus from changing its RNA into proviral DNA. Other antiretroviral drugs 
inhibit the formation of new viruses by paralyzing the protease enzyme and so 
preventing the assembly and release of newly replicated HI Viruses from the infected 
cells. 
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The increasing affordability of antiretroviral drugs to suppress HIV and the technical 
monitoring of the drugs actions in people‟s bodies offers hope for preventing hundreds 
of thousands of deaths each year (Poku 2005:128). 
So it is essential to always have these drugs available in health care facilities to ensure 
that those who are in need have access to treatment. The benefits of antiretroviral 
treatment cannot be overemphasised. They range from a reduction in opportunistic 
infections, including the most common in South Africa such as TB to a substantial 
reduction in HIV transmission as a result of universal treatment. Antiretroviral treatment 
reduce viral load, reduce mortalities, and increase the quality of life of HIV patients. The 
direct benefits of antiretroviral treatment consist of increased productivity of those living 
with HIV, a reduction of the socioeconomic impact of HIV and AIDS, and a reduced 
exposure to stigma for antiretroviral patients whose better health status makes them 
less identifiable. With early treatment, these benefits are increased. However, while 
early treatment in South Africa is expected to be beneficial, it has possible implications 
for funding shortfalls, a deterioration in the health care system, and uncertainty 
regarding its effect on risk behavior and new HIV transmission (Smith 2013:255). 
Development in medical technologies had multiple effects. In the affluent countries of 
the developed world, they have changed the apocalyptic character of public discourse 
regarding HIV and AIDS. Today in the developed world, HIV is often characterized as a 
chronic and manageable disease. Improved treatment technologies have also changed 
the shape of the developed-world HIV advocacy and activism. 
The advent of effective HIV treatment has sharpened focus on disparities in treatment 
access and delivery between different parts of the globe. However similar disparities 
exist within countries, where refugees cannot secure fully-fledged citizenship and the 
related rights to health care, where radicalized, sexualized, gendered and economically 
disempowered social groups experience HIV service exclusion, and where HIV service 
provision may differ radically between geopolitical areas and across urban and rural 
communities. The various histories and epidemiologies of HIV epidemics, different 
levels of prevalence, varieties of political ownership and response, and widely divergent 
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resource availability also strongly differentiate prevention and treatment technologies 
(Lovett-Scott and Bartlett 2014:13). 
Across all these situations, antiretroviral treatment has nevertheless defined „new‟ post-
treatment or treatment possibility generations, emerging in the mid-1990s in the 
developed world and post-2003 in most developing countries. These generations differ 
widely in the medical and other resources available to them, but have some potentially 
shared assumptions about living with HIV and the risks of HIV transmission. HIV 
positive people taking antiretroviral treatment in the developing world are also now 
having experiences similar to those in developed-world countries living long term with 
HIV medication. However, in the developing world, this group continues to live 
alongside large numbers of people who need but cannot access antiretroviral treatment, 
as well as large numbers of people newly infected each year. Moreover, effective 
treatment, or its possibility, arrived at very particular times within each epidemic. For 
instance, ART became available only after many HIV positive people in developed 
countries and some African countries, such as Uganda and Tanzania, had died. Within 
other low-resourced countries such as South Africa, where the epidemic developed 
later, this second, post-treatment or treatment-possibility generation involves people 
doing well on ART, living alongside many who are dying (Davis and Squire 2010:4). 
2.2.4 Antiretroviral treatment in South Africa  
The provision of antiretroviral treatment has been a serious challenge in South Africa 
and this dated back in 2004.The roll-out programme of antiretroviral treatment in 2004 
was slow due to the fact, that the state avoided financing the public provision of 
antiretroviral treatment. The presence of antiretroviral treatment in public health care 
system might be determined by the structural functionalism of the roll-out programme, 
and the capacity to facilitate the roll-out of antiretroviral drugs and ideological opposition 
to antiretroviral treatment in the health care facilities. The study uncovers those 
underlying factors that determine the existence of poor or good accessibility of 
antiretroviral treatment in public health care facilities in Ermelo. For a full functional roll-
out program to be successful there is a major need for human capacity. Human capacity 
comes at the expense of capital and in a country that is still developing and faced with 
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many social challenges; the capacity strengthening might be a pipe dream (Squire 
2007:42). 
The researcher„s view is supported by the slow reaction by the public health sector to 
introduce pre-exposure prophylaxis to people at risk. PrEP as it is familiar known is 
currently conceived or imagined as similar to the contraceptive pill or to an anti-malaria 
pill.  
It has been stated that PrEP consists of „one pill a day‟ made up of the HIV antiretroviral 
drug Tenofovir which, in some instances, is combined with Emtricitabine and called 
Truvada. Both Tenofovir and Emtricitabine are used as part of HIV antiretroviral 
combination treatment (ART).The researcher believe that, the slow introduction or the 
reluctance to introduce the PrEP in public health care facilities is perpetuated by the 
notion which, forms the concluded perception of the decision makers in government 
that, the provision of PrEP might discourage the use of condoms. This view is totally 
unfounded as it is not supported by empirical findings. Infection rate still continue to rise 
despite the availability of free condoms in every part of this country. Mortality rate still 
rise despite the provision of communication education and programs to combat HIV and 
AIDS. Access to antiretroviral treatment to everyone who wants to use them either as a 
PrEP or Post-exposure prophylaxis must be made possible in public health care 
facilities across the country (Davis and Squire 2010:168). 
HIV treatment includes the use of combination antiretroviral therapy to attack the virus 
itself, medications to prevent and treat the opportunistic infections that occur when the 
immune system is compromised by HIV. 
The issue of access to treatment is not simply a matter of antiretroviral medication since 
there is a need to ensure that, relatively inexpensive drugs are available for 
opportunistic infections such as TB and diarrhea (The Henry Kaiser Family 2015:2). 
It has been indicated that in many countries access to drugs and other material inputs 
needed for effective care of those with HIV-related illnesses are generally not available 
for reasons often of resource constrains. In South Africa, the response of government in 
general has been to argue that there are budgetary constraints limiting access to 
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antiretroviral treatment, and that these constraints will continue for the foreseeable 
future (Poku  2005:131). 
The researcher assert that, certain conditions can be identified as important in 
determining improved access to treatment for those living with HIV and AIDS. These 
conditions can be broadly grouped into two categories: challenges related to demand 
and challenges related to supply. The supply challenges are associated with the 
logistical problems of taking this massive demand in the context of the existing deficits 
in political will, health system including leadership, human resources, technical 
expertise, physical infrastructure, equipment and supplies.  
According to UNAIDS (2005:17) there are seven challenges that have been identified as 
contribution factors that preclude effective, long-term, or widespread development in 
Africa. The contributing factors are the legacy of Africa‟s history (post-colonialism has 
been unable to overcome deep divisions). The cycle of poverty, inequality, and disease 
(rising populations put pressure on inadequate social sector infrastructure, and AIDS 
further depletes capacity. The divisions rupturing society (scarcity promotes division, 
HIV and AIDS stigma feed off divisions).  
The quest for swift dividends African leaders and their donor partners want to show 
quick results, so are unable to invest in long-term change).The challenges of 
globalization: integration and marginalization (trade rounds and reducing foreign 
investment fail to benefit Africa, worse formal economy is left to rely on a narrow 
primary export base). Aid dependency and the quest for global security (aid donors fail 
to live up to the rhetoric of harmonization and the so-called global war on terrorism spills 
over into Africa, determining donor funding patterns). The other factor is the response to 
HIV and AIDS epidemic: shortcuts and magic bullets (the scramble to roll out 
antiretroviral therapy, leaves few lasting benefits, and prevents the much needed scale-
up of HIV prevention) (UNAIDS 2005:18). 
2.2.5 Challenges of rolling out ARVs 
For the roll out program and the improved accessibility of antiretroviral treatment to be 
improved there must be a full commitment from the range of key stakeholders. It must 
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also be noted that in the African context, limited human, physical and financial 
resources present major barriers to scaling up treatment provision. It must be noted that 
most African countries had severe capacity constraints and were not meeting the health 
needs of their populations long before HIV and AIDS even existed (Poku 2005:142). 
UNAIDS (2005:17) further suggest that, traps and legacies describes how HIV and 
AIDS does catalyze people and institutions into a response, but they cannot make 
sufficient headway with depleted capacities and infrastructure. The additional burden of 
responding to the HIV and AIDS epidemic detracts from other development effort-
continuing underdevelopment in turn undermines the ability of many countries to get 
ahead of the epidemic. The spate of xenophobic attacks in South Africa had an effect in 
the patterns of resource distribution in Africa. International relation and trade relations 
might have also been affected by the xenophobic attacks. 
It has been pointed out that there is problems of fatigue and complacency represent 
important challenges in nations at the vanguard of coping with the disease. This 
complacency and fatigue are not merely individual attitudes, but also critical social 
issues. The researcher realized that there is an important role to be played by activists, 
both from within and from outside of government in bringing these issues to the 
attention of the public health leaders, who fund, formulate and implement HIV 
prevention programme (Pandamsee and Klein in Smith 2013:271). 
Various perceptions are expressed by different patients in health care domain. Their 
perceptions are based on their experiences while receiving medical assistance in the 
form of antiretroviral treatment. In Ermelo Regional Hospital there are wellness 
programme designed to specifically provide antiretroviral treatment to HIV and AIDS 
patients. The determination of whether there is poor accessibility or good accessibility is 
answered by the empirical findings of this study which will be interpreted at the later 
stage. 
According to Whiteside and Barnett (2002:05) for the last 20 years a few academics and 
policy makers have debated whether or not HIV and AIDS has social and economic 
impacts and what they might be. Most have preferred to ignore and deny the problem. 
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The authors have spent much of this period researching these issues. We have looked 
at what HIV and AIDS does to the lives of individual, communities, companies and 
societies. It is surprising how few senior policy makers and even fewer politicians have 
been prepared to consider the potential consequences of the epidemic and what should 
be done about them. In part this has been the result of the glacial pace at which 
governments and international organizations are able to move and change. Politicians, 
policy makers, community leaders and academics have all denied what was patently 
obvious-that the epidemic of HIV and AIDS would affect not only the health of 
individuals but also the welfare and well-being of households, communities and, in the 
end, entire societies. The effects of diseases are rarely considered beyond the clinical 
impact on individuals. 
UNAIDS (2005:18) indicated that efforts in Africa to roll-out antiretroviral treatment 
continues, but are impeded by a combination of underdeveloped and overwhelmed 
systems and overall costs. 
Accessibility of the antiretroviral treatment is determined by the effectiveness of any 
national intervention program. South Africa health system also has its own intervention 
programs. Those programs are aimed at dealing with the scourge of HIV and AIDS in 
public health care system. The researcher wonders whether the available local 
intervention plan yields the desired results. Results of the impact are determined by the 
sustainability of the intervention. 
Smith (2013:31) defines sustainability as a process within a local system whose aim is 
to maintain improved health status. This local system is composed of local stake-
holders (individuals, communities, and local organizations) that operate within a larger 
environment. A sustainable process enables these local stakeholders to express their 
potential through balanced improvements in several key components - service delivery, 
organizational capacity, and community capacity. The actors within the local system 
improve their functioning and develop mutual relationships of support and 
accountability. The researcher believes that sustainability of any program will be tested 
by monitoring and evaluation of such program. 
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It has been argued that, there are critical and uncertain forces driving HIV and AIDS in 
Africa. Five powerful driving forces were identified in the project as being crucial to the 
future of HIV and AIDS in Africa. These drivers each have their own dynamic and 
operate at many different levels, from the house hold and community, to the regional 
and international arenas. In addition, these drivers interact, creating further complex 
dynamics. One of those five powerful driving forces is the leveraging of resources and 
capabilities. The struggle against HIV and AIDS is sometimes presented as simply a 
question of funding. It has been demonstrated that considerably more resources are 
needed; the issue is also about leveraging what is available to achieve more-especially 
when resources are limited. Resources include money, leadership, human capacity, 
institutions and systems. It is clear that resources may become exhausted under the 
pressures of the epidemic and the underdevelopment. Funds could be dissipated in 
short-term, conflicting initiatives, with little long-term benefit (UNAIDS 2005:13). 
According to Ige and Quinlan (2012:100), the civil society response in South Africa to 
AIDS prevention and treatment services has been constituted largely under the 
auspices of the South African National AIDS Council (SANAC). The SANAC was 
established as an independent body in 2000 but restructured in 2006 to make it more 
effective and accountable in overcoming the HIV and AIDS epidemic. This followed a 
criticism that SANAC was not genuinely representative of civil society and that its 
process were erratic. SANAC is a multi-sectorial partnership body comprised of top-
level government representative and elected civil society representatives from a wide 
range of sectors. SANAC has been viewed as playing a management and advocacy 
role in strengthening mobilization, monitoring and providing national oversight in 
response to HIV and AIDS. It is specifically tasked with advising government on HIV 
and AIDS related policy, creating and strengthening partnerships for an expanded 
national response and mobilizing resources for SANAC partnership activities. 
Establishment of SANAC somehow contributed positively in the accelerated process in 
the provision of ARVs. 
Life expectancy of South Africans for both males and females has significantly improved 
to 62 years, which is an increase of eight and a half years since 2005. The HIV policy 
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turnaround in 2015 led to a massive roll-out of HIV testing and treatment for 8.2 million 
people living with the virus. This has contributed immensely to healthier and longer lives 
for those infected (Vuk‟uzenzele 2016:09). 
Deputy President Cyril Ramaphosa has launched the national campaign for girls and 
young women called Phila. It was launched after it has been estimated that 2 000 girls 
and young women between the ages of 15 and 24 get infected by HIV in South Africa 
each week (ENCA News 2016). 
Government, through the Ministry of Health, aims to revive prevention campaigns, 
especially amongst the youth. The state-owned pharmaceutical company, Ketlaphela, 
has been established to supply antiretroviral drugs to the National Department of Health 
from the 2016/17 financial year. The white paper on National Health Insurance (NHI) 
was released in December 2015 for public comments. NHI is aimed at achieving 
universal access to health care for all people in South Africa (Vuk‟uzenzele 2016:09). 
The establishment of the state-owned pharmaceutical company clearly indicates that, 
there is an existing challenge in scaling up of antiretroviral treatment in the Public 
Health Care facilities across the Republic of South Africa. The company has been 
established to participate in the supply of anti-retroviral treatment to the National 
Department of Health from 2016/2017 financial year. The president of the Republic of 
South Africa Jacob Zuma indicated that the country‟s HIV policy turnaround in 2009 has 
led to a massive rollout of HIV testing and treatment for 3.2 million people living with the 
virus (Vuk‟uzenzele 2016:11). 
Evidence across the globe attests that, the challenges for largest number of people with 
HIV and AIDS, however, is obtaining the drugs/treatment in the first place. Combination 
therapies are expensive; for example, the new combination ART drug, Atripla, costs 
approximately $25,000 per year. In addition, there are costs for other drugs to manage 
symptomps and opportunistic infections. Those who have health insurance are 
protected from some of these large costs. For most, however, including those without 
insurance, without personal resources, and on medical aid, the cost is high, often 
prohibitively so. In the USA, we know that the HIV and AIDS epidemic has moved into 
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socioeconomically disadvantaged populations that do not and will not have access, 
either directly or through public or private social services, to the funds for combination 
therapies. In developing countries, where the epidemic is spreading most rapidly and 
where money for care is limited, few resources are available for combination therapies 
(Fan et.al 2014:188). 
The benefits of access to treatment cannot be overemphasized. They range from a 
reduction in opportunistic infections, including the most common in South Africa such as 
tuberculosis, to a substantial reduction in HIV transmission as a result of universal HIV 
testing and immediate treatment. ARV treatment suppresses viral loads, reduce 
mortality, and increase the quality of life of HIV patients (Smith 2013:255).  
 2.2.6. The effect on funding 
An immediate effect of early treatment is the need for more funding to treat additional 
patients. Given the fact that affordability of HIV and AIDS treatment in South Africa 
always has been an issue, the question that arises is whether the country is likely to be 
able to afford early treatment in the future. While an immediate answer to this question 
remains elusive, it can be understood through an analysis of past HIV and AIDS 
treatment funding trends and future funding prospects (Smith 2013:255-256). 
The South African government under President Jacob Zuma showed a clear 
commitment ensuring that treatment is accessed by all South Africans, but the main 
issue is sustainable funding that is currently received. 
It has been noted that South African government generally fund its policies in two ways: 
equitable share grants (or unconditional grants) and conditional grants. Equitable share 
grants are received by provincial and local governments directly from the National 
Revenue Fund (NRF) thought of as “a bank of revenue for the government”. The term 
“equitable share” signifies the fairness with which these funds are distributed. Provincial 
and local governments receive the money based on a formula that takes their needs (in 
terms of health status, education, population, poverty level, and administration) into 
account, although they do not need to abide by the formula in spending the money, 
which makes the grant unconditional. Conditional grant funding consists of money 
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received by provincial and local governments indirectly from NRF via the national 
government, which has to spend according to national government priorities (Free State 
Department of Health, 2010). 
The national government‟s HIV and AIDS funding trends can be understood by 
examining its conditional grants to provincial and local governments‟ HIV and AIDS 
programs. These conditional grants are channeled through three social sector 
departments: the National Department of Health, which is mainly responsible for HIV 
and AIDS treatment; the department of social development, which is responsible for 
social HIV and AIDS programmes; and the department of Education, which is 
responsible for HIV and AIDS life skills programmes. The increase in funding for HIV 
and AIDS treatment since 2004 does not, however, provide a clear picture of the extent 
to which the country has met the funding requirements of its treatment policy. Funding 
shortfall can have a direct consequence in the number of people on treatment (Smith 
2013:256). 
The researcher holds a view that increasing funding in order to provide early treatment 
to eligible patients would require a significant increase in revenue. Increasing revenue 
will require an increase in tax rates and/or an increase in taxable income. 
Donors have thus far played a significant role in HIV and AIDS funding in South Africa, 
but this source of funding is bound to shrink in the short term. In particular, European 
countries have been contributing to South Africa HIV and AIDS treatment via their 
donations to global fund to fight HIV and AIDS, Tuberculosis and Malaria (Smith 
2013:260). 
Karim and Karim (2010:503) argued that, suitable infrastructure is needed to manage 
HIV-infected individuals at primary care level, but funding is not readily available and 
qualified health care personnel are in short supply. Private health care attracts most 
health care funding, but is accessed by less than 20% of South Africans. The effective 
use of antiretroviral therapy requires meticulous adherence. Poverty, alternative disease 
constructs, stigma, gender and unpredictable drug supply are important factors 
influencing adherence. South Africa is undergoing a period of profound socioeconomic 
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development, and the HIV and AIDS epidemic presents the medical system with 
extraordinary health care challenges. Many factors that affect regimen selections 
include costs. 
The medicine management cycle is an essential component when considering 
implementation of antiretroviral treatment in South Africa. This is traditionally portrayed 
as a cycle in which choosing medicines must be followed by procurement, distribution 
and use. The disintegration between the public and private sector in South Africa 
continues to complicate all parts of this cycle. Examining all aspects of the medicine 
management cycle is essential when considering the most effective way to implement 
antiretroviral treatment in South Africa (Karim and Karim 2010:551). 
Exploring accessibility of antiretroviral treatment amongst people living with HIV and 
AIDS at Public Health Care facilities also assist in understanding the medicine 
management cycle in that particular facilities. A choice of a medicine or a group of 
medicine must be followed by processes to ensure its efficient purchase (procurement), 
and then by actions that ensure accessibility at the point of care (distribution), followed 
by steps to ensure the necessary conditions for effective prescription, supply and 
ultimate consumption by the patient (use). The final step is to make sure that future 
selection decisions are informed by these steps, so continuing the cycle. The cycle is 
supported by various management functions (including the organizational design 
features and operations of the health system, its financing mechanisms, information 
technology resources and human resources), as well as by the policy and legal 
framework within which the system operates (Karim and Karim 2010:552). 
Funding is perhaps one of the most difficult factors to address as access reliance is 
placed on a nation‟s ability to fund health care (Prather and Lovett-Scott 2014:35). 
 2.2.6.1 HIV Policy change in South Africa 
Exploring accessibility of antiretroviral treatment amongst people living with HIV and 
AIDS at public health care facilities in Gert-Sibande Region of Mpumalanga province in 
South Africa cannot be done distinctively so, without examining National policies on HIV 
and AIDS. 
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After some years of controversy regarding its attitudes toward HIV and AIDS policies, 
the South African government has shown serious commitment to HIV and AIDS policy 
making since 2007. Previously ARV treatment in South Africa was initiated for patients 
with 200 CD4 counts or below. One of the previous policies in this regard concerns the 
raising of the treatment threshold from 200 CD4 counts to 350 CD4 counts referred to 
as early treatment (Smith 2013:253). 
 Government updates HIV policy to allow ARV treatment for all South Africans (Child 
2016:1). All HIV positive South Africans will qualify for anti-retroviral treatment from 
September 2016 regardless of their CD4 count (measure of immune system strength). 
Currently, patients have to have a CD4 count of 500 to qualify for anti-retroviral. But the 
World Health Organization (WHO) recommends that as soon as a person tests HIV 
positive they should start treatment. This is even they feel healthy. Long term research 
showed people who start ARV treatment earlier get less sick and are likely to live 
longer. People on treatment correctly stop the virus replicating are therefore not 
infectious so the more people on treatment, the lower the new infections rate will be 
(Child 2016:1). 
The minister announced this policy change during his budget vote speech in parliament. 
Professor Salim Karim, Director of AIDS Research Centre Caprisa, said “the Minister‟s 
announcement is undoubtedly a step in the right direction”. He continued “This policy 
change has been expected and follows hard on the heels of the December World 
Organization guidelines on antiretroviral treatment. The impetus for this policy change 
emanates from compelling new evidence from the Strategic Timing Anti-Retroviral 
Treatment (START) trial presented at the Vancouver AIDS conference last year”. 
A 2011 trial conducted in 35 countries called the Strategic Timing Anti-Retroviral 
Treatment (START) study had 4,685 HIV positive participants, half who started HIV 
treatment as soon as they were diagnosed. The other group waited until their CD4 
count dropped below 350. The group that started treatment later had double the 
incidence of TB, Non Hodgkins Lymphoma, Karposi Sarcoma (skin cancer) and a non-
HIV related diseases such as heart attacks and certain cancers-86 versus 41 in the 
group who had treatment immediately. The evidence that starting treatment early was 
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so compelling that the trials was stopped early as it became unethical to delay treatment 
to those not receiving it (Child 2016:2). 
It has been clearly demonstrated scientifically that, early therapy conveys a double 
benefit, not only improving the health of individuals but at the same time, by lowering 
their viral load, reducing the risk of transmitting HIV to other persons. These findings 
have global implications for the treatment of HIV and AIDS. It has been also stated that 
Sex workers who are negative have qualified for free Truvada to prevent them 
becoming positive since December 2015 (Child 2016:2). 
 
 2.2.6.2 Challenges on the policy 
If everyone eligible under an early treatment policy were treated and new HIV 
transmission decreased to a significant extent, then the early treatment policy would be 
sustainable. However, the issues in earlier sections about resources constraints to put 
on treatment everyone who needs it, the possibility of high HIV transmissions as a result 
of an increase in risk behavior and the effect of other factors that influence HIV 
transmission (Smith 2013:264). 
It was noted that despite the country‟s effort to increase funding since 2007, all eligible 
patients did not receive treatment at least until 2012. It was further found that the 
economic prospects of the country and other international sources of funds did not 
indicate a promising future with respect to fundraising. A plausible strategy for these 
issues would be to ensure that everyone eligible for treatment under the policy is treated 
while at the same time strategies to reduce significantly new HIV transmission are 
adopted. Designing interventions that follow up patients on treatment and their potential 
partners requires considerable resources. It has been noted with great concern that 
there is also a significant amount of people who defaulted treatment and feel scared to 
go back for treatment. Early treatment policy is likely to aggravate the state of the 
current health care system, which is characterized by inequity and inefficiency inherited 
from the apartheid system (Smith 2013:266). 
32 
 
2.2.7 Public Health Care facilities in South Africa 
HIV and AIDS have become an added burden on already strained health care systems. 
The full extent is not yet apparent because of the latent period between infection and 
illness and death. Data on the effect of HIV and AIDS on health care systems are 
scarce, most studies being small and cross-sectional (Karim & Karim 2010:359). 
The main impact on adult health services appears to be increased hospital admissions, 
leading to ward overcrowding and possible exclusion of HIV negative patients as a 
result. It is unlikely that the public health sector is going to be able to sustain the 
increasing costs of treating HIV positive patients, which means that some form of 
rationing is inevitable and is probably already happening (Karim & Karim 2010:359). 
The researcher is of the view that, the evidence clearly suggests that HIV and AIDS are 
now the leading cause of morbidity and death in Sub-Saharan Africa, including South 
Africa and the epidemic has therefore become an added burden on already strained 
health care systems. 
2.2.8 Conclusion 
This Chapter provided literature review from multiple sources regarding accessibility of 
antiretroviral treatment and the significant of accessing such treatment. The Chapter 
also examined the historical overview of the pandemic, the theoretical frame work and 
the description of the health belief model. The antiretroviral treatment in South Africa 
was also reviewed and challenges of rolling out antiretroviral treatment. The state of 
public health care facilities in South Africa was also examined. 
The following Chapter presents the research design and the research methodology 
used in the study. 
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CHAPTER THREE 
RESEARCH METHODOLOGY 
 
3.1 Introduction 
Chapter 3 outlines the research design and research methods used in this study. Each 
of the methods is discussed in line with the purpose and objectives of this study. 
Based on the evidence reviewed from the literature in Chapter 2 the researcher opted 
for qualitative research design to explore the perceptions of participants‟ accessibility of 
antiretroviral treatment in health care facilities in the Gert-Sibande Region. 
Bless et.al (2006:43) defines research methodology as an approach employed to 
conduct research where a distinction is drawn between qualitative and quantitative 
research, applied and basic research, and between exploratory, descriptive, 
correlational and explanatory research. 
Qualitative research was adopted for this study based on the fact that, it allowed the 
researcher not only to explore the experiences and perceptions of participants on 
wellness programs receiving antiretroviral therapy in Gert-Sibande Region health care 
facilities. It also give the researcher an opportunity to gain knowledge and more 
understanding about accessibility of antiretroviral treatment in health care facilities in 
Gert-Sibande Region (Babbie 2010:296). 
In this Chapter, research design, research methods, sampling, data analysis, validity of 
the study and ethical considerations are discussed in more details. 
3.2 The Research Design 
Babbie (2010:92) state that social research is conducted to explore a topic, that is, to 
start to familiarise a researcher with that topic. This approach typically occurs when a 
researcher examines a new interest or when the subject of study itself is relatively new. 
Exploratory research is fundamentally used to explore a new topic or to learn more 
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about issues where little is known. The qualitative nature of the research allowed the 
researcher to explore more deeply the perceptions of people living with HIV and AIDS 
and the capabilities of the provision of antiretroviral treatment at health care facilities in 
Gert-Sibande Region of the Msukaligwa Municipality in Mpumalanga. 
3.3 Research Method 
Interviews have been employed for this study. It has been indicated that interviews are 
discussions, usually one-on-one between an interviewer and an individual, meant to 
gather information on a specific set of topics (RAND Corporation 2009:06).  
Kumar (2011:144) define interviews as a commonly used method of collecting 
information from people. Any person-to-person interaction, either face to face or 
otherwise, between two or more individuals with a specific purpose in mind is called an 
interview. Face to face interviews are used for this study based on the fact that a 
researcher had a freedom to decide the format and content of the questions to be asked 
to the participants. This had been done with the opportunity in choosing wording of the 
questions the way in which they would be asked and the order in which they are asked. 
3.3.1 Semi-Structured Interviews 
Cohen and Crabtree (2006) indicated that semi-structured interviewing is characterised 
by the interviewer and the participants engaging in a formal interview. The interviewer 
develops and uses an interview guide. The interview guide comprises of the list of 
questions and topics that need to be covered during the conversation, usually in a 
particular order. The interviewer follows the guide, but is able to follow topical 
trajectories in the conversation that may stray from the guide. 
Kumar (2011:149) notes the significance of semi-structured interviews as a strategy for 
obtaining information from participants as it is more appropriate for complex and 
sensitive areas. The researcher opted for this tool of collecting data based on the fact 
that it was difficult to obtain more than one chance to interview participants. Semi-
structured interviews afforded the interviewer with an opportunity to prepare participants 
before asking sensitive questions and to explain complex ones to participants in person. 
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In-depth information was uncovered during the interviews and observations were also 
made from non-verbal reactions. 
In this study, the researcher was offered and office located next to the wellness center. 
Participants were recruited at a very close proximity. The location of the office gave 
participant comfort in terms of expressing their personal experiences about accessing 
antiretroviral treatment in the health care facility in a detailed and in private space. The 
interviews which lasted between 10 to 36 minutes each was also done there with little 
interruption and other disturbances. 
The structure of the interviews included and introduction to the research, and 
explanation of the research ethics, explaining to participants the purpose of audio 
recording, obtaining permission to record each conversation from each participant, 
starting with broad research questions, based on the purpose and objectives of the 
study and were open-ended, and moving to the sub-questions and finally closing the 
session by asking for any additional comments or remarks. Probing questions were also 
used to allow participants to answer in more detail about the subject matter. The 
researcher continually reminded the participants to stop him if they no longer feel 
comfortable about the questions or the study itself. The participants were males and 
females 18 years and above speaking predominantly in isiZulu and siSwati. 
3.4 Sampling 
Sample was drawn from persons who are 18 years and above and attending wellness 
program at Gert-Sibande Regional Public Health Care facility in Mpumalanga Province. 
Neuman (1997:201) defines sampling as a process of systematically selecting cases for 
inclusion in a research project. Babbie (2010:192) asserts that there are two general 
types of sampling procedures which are probability sampling and non-probability 
sampling. Babbie (2010:192) further indicated that there are four types of non-
probability sampling which are: reliance on available subjects, purposive (judgmental) 
sampling, snow ball sampling and quota sampling. If a non-probability sampling 
procedure is used, the researcher can only hope that those selected for study bear 
some likeness to the larger group. Participants come from a heterogeneous 
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background. The likeliness of participants in this study is their intake of antiretroviral 
medication and attending a wellness programme at the Public Health Care facility. 
Non-probability sampling procedure includes accidental quota sampling, purposive 
sampling and systematic matching sampling. While useful for many studies, non-
probability sampling procedures provide only a weak basis for generalization (Neuman 
1997:208). 
So the researcher chose purposive sampling for this study. Participants were 
purposively or judgementally sampled. In this study, participants were selected on the 
basis of their characteristics, elements, and the purpose of the research. Participants 
were selected on the basis of their HIV status and their attendance of the wellness 
program in public health care facilities in Gert-Sibande region of Mpumalanga Province. 
Participants receive antiretroviral treatment and come from diverse backgrounds. 
According to Babbie (2010:193) purposive or judgmental sampling is a type of 
nonprobability sampling in which the participants to be interviewed are selected on the 
basis of the researcher‟s judgment about which ones are the most useful or 
representative to the whole population. Those who were attending wellness program 
and not yet receiving antiretroviral treatment were excluded in the study. Those persons 
under the age of 18 years but already on antiretroviral treatment were also purposively 
excluded. 
3.4.1 Sample Size 
According to Neuman (1997:221) sample size is determined by the kind of data analysis 
the researcher plans to employ and how accurate the sample has to be for the 
researcher‟s purposes, and on population characteristics. Bouma and Ling (2004:125) 
argue that in general, large samples are not necessarily better than smaller ones. 
Sample size in this study comprised of twenty three (23) participants selected 
purposively. These participants were drawn from a heterogeneous population. Bless et 
al (2006:108) assert that a researcher‟s decision about the best sample size depends 
on three things: The degree of accuracy required, the degree of variability and diversity 
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in the population. The researcher targeted people who are living with HIV who is already 
on antiretroviral treatment and attending wellness programme in the health care 
facilities. 
3.5 Data Analysis 
The study employed qualitative data analysis. Babbie (2010:393) define qualitative data 
analysis as the non-numerical assessment of the observation, content analysis, in-depth 
interviews, and other qualitative research techniques. During data analysis the 
researcher formed new concepts and refined those concepts that are grounded in the 
data. Neuman (1997:421) assert that concept formation is an integral part of the data 
analysis and begins during data collection.  
Researcher developed new concepts, formulated conceptual definitions and examines 
the relationships amongst concepts. The researcher also created thematic 
categorization and transcribe the data which was collected to ensure that empirical 
findings are uncovered for this study. 
By analyzing data the researcher managed to organize data and applied ideas 
simultaneously to create or specify a case. This method of creating a case called 
casing, brings the data and theory together (Neuman1997:421). 
So due to the fact that, data was collected using recording device, the researcher had 
an opportunity to transcribe the data and follow the above mentioned processes to 
ensure that findings are more comprehensive and detailed. 
The analyzed data managed to bring order, structure and meaning to the mass of data 
collected. This was central to the aim of the data gathered from semi-structured 
interviews, based on the evidence emanated from the themes and sub-themes which 
again based on the purpose and objective of the study (Adendorff 2015:37). 
The qualitative data of this study was transcribed and then analysed in a step-by-step 
process (Babbie 2010:297).The aim of the research was to organise the information into 
codes/categories or themes. A specific coding was done to similar themes and 
clustered them into research questions. All these codes were then reverse-integrated 
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into themes and sub-themes. Patterns and themes were identified, outlined and 
summarized in Chapter 4. 
 
3.6 Validity of the Study 
According to Babbie (2010:327) validity concerns whether measurements actually 
measure what they are supposed to rather than something else. Kumar (2011:184) 
indicated that validity of the study refers to the ability of a research instrument to 
demonstrate that it is finding out what you designed it to. 
3.6.1 Trustworthiness 
According to Kumar (2011:185) trustworthiness is determined by four indicators which 
are credibility, transferability, dependability and confirmability. 
3.6.1.1 Credibility 
Credibility involves establishing that the results of qualitative research are credible or 
believed from the perspective of the participants in the research. Qualitative research 
explores perceptions and experiences about accessibility of antiretroviral treatment in 
public health care facilities in Gert-Sibande Region in Mpumalanga. It is believed that 
the participants in this study are the best judge to determine whether or not the research 
findings have been able to reflect their opinions and feelings accurately. That opinion 
determination was done during the debriefing session with the participants. 
3.6.1.2 Transferability 
The results of this study yield a high level of generalizability and transferability to other 
contexts or settings. The researcher opted to keep records of the processes he 
undergone during the conduction of this study to allow other researchers to follow and 
replicate the results. 
3.6.1.3 Dependability 
The researcher holds a strong view that the results of this study are very dependable 
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3.6.1.4 Confirmability 
The research results in this study could be confirmed or corroborated by others. If the 
similar research is taken within the specified period, chances of obtaining similar results 
are very huge, however one need to bear in mind that circumstances and conditions 
constantly changes (Kumar 2011:186). 
3.7 Ethical Considerations 
The researcher asserts that, the ethical considerations concerning participants and 
good data management were maintained throughout the study ( see informed consent 
form as Appendixes and Institutional Ethical Clearance Certificate).During the conduct 
of this research ethical clearance were obtained from the University of South Africa and 
Mpumalanga Department of Health. Berg et.al has said (quoted in Adendorff 2015:39), 
it is generally accepted that since researchers in the behavioral sciences typically 
conduct research that involves human subjects, ethical considerations are the 
responsibility of the researcher. 
The following ethical considerations were maintained during the study: 
3.7.1 Informed Consent 
Babbie (2010) indicated that the ethical norms of voluntary participation and no harm to 
participants have become formalised in the concept of informed consent. In this study 
participants indicated their willingness to participate in the study voluntarily and consent 
forms were signed by the participants before the commencement of the study. The 
participants also willing fully divulge their identities to the researcher and gave consent 
to take part in the study. Anyone who meets the inclusion criteria and volunteer to take 
part in the study had to sign the consent form individually because of the sensitivity of 
the research topic. Those who could not write their names on the space provided due to 
inability to write were encouraged to cross “x” next to the space allocated for the 
signature in the informed consent form. Before the study can take place, each 
participant was given a chance to ask questions about the study and they were 
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reminded of their rights regarding participation and their freedom to terminate the 
interview at any given stage. 
 
3.7.2 Voluntary Participation 
Participation was voluntary and participants were informed that they could at any given 
stage withdraw or terminate their participation in the study and they will not forfeit any 
privilege bestowed to them as patients and services they are entitled to within the Public 
Health Care Facility. 
3.7.3 Confidentiality 
Babbie (2010:67) asserts that research project guarantees confidentiality when the 
researcher can identify a given response with a given participant. The researcher 
assured participants that, the information obtained throughout this study is treated with 
a high degree of confidentiality and the use of an office situated next to wellness center 
assisted in camouflaging every participant. All responses from the participants were 
protected from anyone within the facility and were not made public. Access to the 
interview guides was limited to the researcher throughout the duration of the study. 
3.7.4 Debriefing 
Babbie (2010:70) debriefing entails interviews to discover any problems generated by 
the research experience so that those problems can be corrected. 
In this study a Psychologist working within the public health care facility was always on 
stand-by to deal with any emotional situation that might emanate from the participants. 
In this study participants were debriefed after each interview and were asked about their 
views and experiences of the interviews and whether they wanted to add any additional 
comments or suggestions related to the study. Ethical considerations were adhered to 
and from all the twenty three (23) participants none of them asked for a Psychological 
counseling. Participants largely indicated that they have accepted their HIV statuses 
and received counseling after they have tested positive in their respective health care 
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facilities. Participants indicated that they have adapted and accepted their new HIV 
statuses and had made a significant progress since tested positive. 
 
3.8 Conclusion 
This Chapter focuses on the research methodological steps involved in conducting this 
study. In this chapter, the qualitative, explorative research design of this study was 
explained. Data collection and analysis were properly made and issues pertaining to 
ethical considerations were also discussed. 
In Chapter 4, the researcher reports on the qualitative research findings of this study. 
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               CHAPTER FOUR 
                                             THE FINDINGS OF THE STUDY  
 
4.1 Introduction 
To reflect: the purpose of the study was to explore the accessibility of antiretroviral 
treatment amongst people living with HIV and AIDS at Public Health Care Facilities in 
Gert-Sibande region in Mpumalanga. This was done by exploring the experiences in 
relation to accessibility of antiretroviral treatment amongst people living with HIV and 
AIDS in Health Care Facilities in Gert-Sibande region in Mpumalanga and establishing 
the current state in relation to accessibility of antiretroviral treatment in those facilities. 
4.2 Profile of Participants 
The interviews were conducted with twenty-three (23) participants living with HIV and 
receiving antiretroviral treatment in the Public Health Care Facility in Gert-Sibande 
region. Ermelo regional hospital was chosen as a research site and participants were 
recruited from their wellness program. In order to maintain confidentiality of the 
participants the researcher opted to use numbers to refer to participants. Different 
numbers from 1-23 were allocated to each participant and allocation of numbers was 
done in a sequential order of interviews. Numbers were allocated sequentially meaning 
that the first participant was allocated with number 1.The second participant was 
allocated with number 2  and that form of allocation continued up until the 23rd 
participant. The use of Pseudonyms was not preferred by the researcher instead age, 
gender and language were used to categories participants. The following table indicates 
the profile of participants. 
Table 1.1 Research Participants 
Participant Age Gender Language 
Participant 1     61 years Female Si Swati 
Participant 2 50 years Female Si Swati 
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Participant 3 67 years Female Isi Zulu 
Participant 4 45 years Male Isi Zulu 
Participant 5 45 years Male Si Swati 
Participant 6 27 years Female Isi Zulu 
Participant 7 28 years Female Isi Zulu 
Participant 8 58 years Female Si Swati 
Participant 9 40 years Male Isi Zulu 
Participant 10 29 years Female Isi Zulu 
Participant 11 25 years Male Isi Zulu 
Participant 12 46 years Male Isi Zulu 
Participant 13 49 years Female Si Swati 
Participant 14 59 years Male Si Swati 
Participant 15 26 years Male Isi Zulu 
Participant 16 40 years Female Si Swati 
Participant 17 64 years Female Isi Zulu 
Participant 18 49 years Male Shona 
Participant 19 53 years Male Tsonga 
Participant 20 18 years Female Isi Zulu 
Participant 21 19 years Male Si Swati 
Participant 22 21 years Male Isi Zulu 
Participant 23 23 years Male Isi Zulu 
 
As indicated in the table 1.1, the participant‟s age ranged from eighteen (18) years to 
sixty seven (67) years, and thirteen (13) participants spoke Isi Zulu, eight (8) 
participants spoke SiSwati, one (1) participant spoke Tsonga and one (1) spoke Shona. 
The sample‟s composition is influenced mainly by the demographics in the district. It 
has been mentioned in the literature that Mpumalanga is pre-dominantly SiSwati and 
IsiZulu ethnic groups. Eleven (11) participants were females and twelve (12) 
participants were males. Three (3) participants were infected through mother-to-child 
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transmission, meaning that they were born with it and twenty (20) participants were 
infected heterosexually. 
 
4.4 Key Findings 
The following themes were generated after the process of data analysis: 
4.4.1 Theme 1: The capabilities of Gert-Sibande public health care facilities in 
providing antiretroviral treatment. 
All twenty-three (23) participants indicated that they don‟t have any problem in 
accessing antiretroviral treatment. All the participants indicated that they had never 
encountered any shortage of antiretroviral treatment at the public health care facility or 
the research site.  
The participants‟ answers clearly refute earlier suggestions from the literature review 
where it has been stated that various factors, play a bigger part in accessing 
antiretroviral treatment. One of the notable factors was the roll-out program which was 
viewed as less effective (UNAIDS 2014:3).  
 
Access to antiretroviral treatment for example, is seen as a safer behaviour in delaying 
progression of the HIV into a fully blown AIDS in human body. If a person is aware that 
adhering to medication will bring positive changes in his state of health then that person 
is likely to adhere to antiretroviral treatment (Van Dyk 2008:122).The theory also 
suggest that participants were fully aware of the importance of accessing treatment and 
the important part played by the antiretroviral treatment. 
It has been clearly demonstrated by twenty-three (23) participants that access to 
antiretroviral treatment is a significant step towards improvement of health conditions. 
 
The participants‟ views regarding the capabilities of Gert-Sibande public health care 
facilities were as follows: 
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Participant 1 
“Uyazi mina la esibhedlela njengoba bengigula, bangikhipha konke bangiphatha kahle.” 
Here at the hospital they removed everything (operated) and took great care of me. 
“Ayikho into esike siyithole emitholampilo ngoba izinto ziyashoda ,abantu bese beya 
esibhedlela ukuze bathole amakhambi asincedayo.” 
I never experience any shortage of medication at the Hospital; people go to the hospital 
in order to get treatment. 
Participant 2 
“Amaphilisi esiwatholayo awasebenzi kahle emzimbeni bese sigcina siphindela khona 
basinike amanye.” 
The pills that we are receiving, sometimes they were not effective in our bodies; 
therefore we went back to the Hospital to get other pills. 
Participant 3 
“Esibhedlela mangiyolanda amaphilisi ngosuku olunqunyiwe ngiyawathola, angikaze 
ngibuyele emuva ngoba kuthiwa aphelile.” 
When I went to the hospital to fetch my antiretroviral treatment at the specified date, I 
never went home without treatment. 
Participant 4 
“Amaphilisi angiphethe kahle, ngaqala ngo 1992 ukuwathatha kulesibhedlela.” 
Antiretroviral treatment is good for me, since I started taking treatment in 1992 at this 
Hospital. 
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Participant 5 
“Konke kuhamba kahle amaphilisi ngiyawathola. Ngithola amathathu engiwaphuza 
ekuseni na ntambama”. 
Everything goes well with regard to antiretroviral treatment and is always accessible. I 
get three kinds of tablets, and I take them in the morning and in the afternoon. 
Participant 6 
“Anginayo inkinga yokungawatholi amaphilisi selokhu ngaqala ukuwathatha ngo 2013, 
futhi angikaze ngihlangabezane nenkinga yokungawatholi amaphilisi emtholampilo.” 
I didn‟t have any problem in accessing antiretroviral treatment since 2013.I have never 
experience any problem regarding the shortage of antiretroviral treatment at the health 
care facility. 
Participant 7 
“Selokhu ngaqala ukuwathatha ngo Mashi 2016 ngiyawathola”. 
Since I started treatment in March 2016 I always access it. 
Participant 8 
“Angikaze ngifike la ngingawatholi amaphilisi, ngiwathola ngazozonke izinsuku”. 
During all my visits to the Hospital, I always access treatment without any problems. 
Participant 9 
“Uma ngiwalandile ngiyawathola amaphilisi”. 
When I come to collect  antiretroviral treatment, I always access it.  
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Participant 10 
“Ngaqala ngo Juni 2014 e Piet Retief ukuthatha amaphilisi. Angikaze ngithole inkinga 
yokuthi ngingawatholi amaphilisi khona. Manje sengizoqala ukuwathatha e Ermelo.” 
I started taking treatment around June 2014 at Piet Retief, and I have never experience 
any shortage of antiretroviral treatment. 
Participant 11 
“Ngihlala ngiwathola amaphilisi”. 
I always get antiretroviral treatment 
Participant 12 
“Uma sifika esibhedlela sihlale siwathola amaphilisi”. 
When coming for treatment, we always access antiretrovirals treatment. 
Participant 13 
“Ngihlale ngiwathola amaphilisi angibi nayo inkinga”. 
I always get antiretroviral treatment, and I have never had any problem. 
Participant 14 
“Ukutholakala kwemithi nako akunankinga”. 
Accessibility of antiretroviral treatment is very good.  
Participant 15 
“Angikaze ngifike ngingawatholi”. 
I never come for treatment and not receive it. 
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Participant 16 
“Uma ufike ngosuku obekelwe lona uyawathola amaphilisi”. 
Whenever you arrive at a specified date you always receive them. 
Participant 17 
“Ama ARV’s ayatholakala. Noma angangiphathi  kahle bayangishintshela banginike 
amanye”. 
Antiretroviral treatment is accessible. They change treatment if they notice signs of 
complications and side effects. 
Participant 18 
“Amaphilisi engiwatholayo angiphethe kahle futhi angenza ngiphile”. 
The type of antiretroviral treatment that I am currently receiving is fine, and is giving me 
life. 
Participant 19 
“Okwamanje konke kuhamba kahle ngiyawathola amaphilisi”. 
Currently everything is fine and I am able to access treatment. 
Participant 20 
“Sengizoqala ukuwathatha la esibhedlela amaphilisi, phambilini bengiwathatha 
eTholampilo, ngaqala ukuwathatha ngo 2013.” 
This is the first time that I am receiving treatment at this Hospital. Previously I was 
receiving treatment at Tholampilo Hospital since 2013. 
Participant 21 
“Ngazalwa nalo igciwane lengculazi, futhi amaphilisi ngiyawathola.” 
I was born with HIV and I always access antiretroviral treatment. 
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Participant 22 
“Ngaqala ukuthatha amaphilisi kulesibhedlela ngo 2009, angikaze ngingawatholi 
amaphilisi.” 
I  have never experience any problem since I started receiving antiretroviral treatment in 
2009. 
Participant 23 
“I never had any problems, the only problem I have is when I have to come in the 
morning, and there will be a lot of people at the reception”. 
It is evident from the responses above, that a total of twenty three (23) participants had 
no problem in accessing antiretroviral treatment from the Ermelo Regional Hospital 
which falls under the Gert-Sibande region. All (23) participants clearly indicated that the 
general accessibility of antiretroviral treatment is very good at the Ermelo Regional 
Hospital. 
The following sub-theme was created from Theme 1 
4.4.1.1 Structural problems in accessing antiretroviral treatment 
Six (6) participants indicated that they don‟t have problems with the accessibility of 
antiretroviral treatment but they have a problem with how they access the antiretroviral 
treatment. They cited that too much time is wasted at the reception area where files are 
stored and sometimes not found. In that process, the participants indicated that they 
sometimes spend one (1) to two (2) hours waiting to be assisted. This fact was 
corroborated by participants (6), (8) and (23) that in some instances a skeleton 
(temporary) file will be opened upon the realization that their original files are not 
located. This inconveniences participants based on the fact that time was wasted and 
they normally ask permission from their employers to come and get their antiretroviral 
treatment. It has been corroborated by participants (9) and (18).The reception area was 
perceived as a serious challenge and creates unnecessary delays in the process flow of 
accessing antiretroviral treatment.  
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Participant 6 
“Ngezinye izinkathi  uyafika uhlale isikathi eside, uthole ukuthi ufike uhlale one or two 
hours ulindile o nurse basetiyeni”. 
In some instances one could wait for about one to two hours while the nurses are still on 
tea time. 
Participant 8  
“Indawo le selindakuyo kule ngaphambili uthole ukuthi ifayela abaliboni,bagcine 
bangakhele  i skeleton file ukuthi ngithole amaphilisi”. 
The only place where we wait for a longer period is at the reception area. At some point 
I realized that my file has been misplaced, and a skeleton (temporary) file would be 
opened so that I can access antiretroviral treatment. 
Participant 9 
“Nako e reetla for the first time ne re sena information, ba kgona go rethusa ra etsa 
faele. The only thing ke administration in terms of the information and some negative 
attitude from the staff members”. 
By the time we come for the first time, we didn‟t have information and we were helped 
and they opened files for us. The only thing is administration in terms of the information 
and some negative attitude from the staff members. 
 Participant 18 
“I only encounter problems at the reception area because it is always full of people and 
that delays me. The administration at the reception area needs to be sorted out”. 
 
 
51 
 
Participant 23 
“Abasheshi bakunike i help. Phambili bathatha isikathi ukukhipha ifayela”. 
They don‟t help us timeously. At the front (reception area) they take too much time to 
locate a file. 
It appears from the above responses by participants that there are serious issues of 
structural efficacy. It is evident that the above quoted participants actually experienced 
structural problems at the reception area when accessing antiretroviral treatment. The 
fact that participants wait longer periods of time at the reception area before they can 
access files clearly has a negative impact on the participants as too much time is spent 
at the reception area before they  could be referred to the wellness section.  
 For a full functional roll-out programme to be successful there is a need for 
development of human resource capacity. Human resource capacity comes at the 
expense of capital resources, and in a country that is still developing and faced with 
many social challenges, capacity building challenges might be a pipe dream (Squire 
2007:42). 
Although the other eighteen (18) participants never mentioned any delays at the 
reception area, that might have been caused solemnly by the fact that a question was 
never formulated to explore the state of the reception area. The fact that five (5) 
participants individually mentioned that there is a lot of delays at the reception area 
clearly affirm the existence of structural challenges with reference to the roll-out 
programme. 
4.4.2 Theme 2: Things that have to be done in order to improve the accessibility 
of antiretroviral treatment in the Gert-Sibande public health care facilities. 
Participant 4 
“Konke ku right angikaze ngihlangabezane ne zinkinga”. 
Everything is right because I have never experienced any challenges. 
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 Participant 5 
“Isimo sihle”. Sihle asiphoqhi”. 
The situation is fine, and it has never disappointed me. 
Participant 6 
“Sometimes silinda isikathi eside uthole ukuthi  kuyabanda, ugcine uhlala boma one or 
two hours ba ngaku sizi. Isikhathi sokulinda siningi”. 
Sometimes we wait longer periods of time in very cold conditions approximately one or 
two hours without being helped. The waiting period is too long. 
Participant 7 
“Mina ngibona ku right ngalendlela abasebenza ngayo”. 
In my view the current system of providing antiretroviral treatment seems to be good. 
It appears from the statements indicated above that generally participant feel happy 
about the current system of providing antiretroviral treatment and no suggestions were 
made regarding the improvement in the current system. The issue of the delays caused 
by the reception area is also mentioned by participant six (6). 
However, other participants mentioned below viewed the current situation differently 
and they had their own suggestions: 
 
 
Participant 2 
“Inkinga yilendaba  yokuthi silale ema benchene la kubanda khona. Ngicela ukuthi e 
Ermelo bathole o Doctor.  Abekho o Doctor abaneleko.” 
The major problem is the issue of sleeping on the benches where it is very cold. I 
request more Doctors to be hired at this facility because there are not enough Doctors. 
53 
 
Participant 10  
“Lokulinda uthole ukuthi udokotela akekho”. Udokotela bathi  uphumile ngemoto yakhe 
ngasolo ngimlindile”. 
The issue of waiting for the doctor for a longer period. The doctor drove out of the 
facility with his own car even though I am still waiting for him. 
Participant 12 
 “Ngicabanga ukuthi mabenga beka amadate okuthatha  amaphilisi kahle, ngicabanga 
ukuthi kungaba ncono”.Ngihlala ngisala namaphilisi amaningi mangiyo thatha amanye 
futhi.” 
I suggest that if they could coordinate their dates properly, I could first finish the 
previous antiretroviral treatment before being given the next batch, in that way the 
situation could be very much better. 
Participant 14 
“Mina ngicabanga ukuthi baqhashe bo nurse abaningi.”Ama lunch abo bawalungise 
ukuthi noma omunye ase lansthini omunye asale asebenza”. 
I suggest that the Department of Health should hire more nurses. The lunch times of 
those nurses is supposed to be well coordinated by nurse in charge. When one nurse 
goes on lunch the other nurse would remain behind working. 
 
 
Participant 16 
“Mina ngicabanga ukuthi sifanele sikhulume. Labo abahleli emakhaya kufanele 
batshelwe  ukuthi beze ukuzo thatha amaphilisi”. 
I think we have to give health education to those who are sitting at home and encourage 
them to come for treatment. 
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It is evident that regardless of the accessibility of antiretroviral treatment being good, 
there is still a need to improve the process flow. There is also the issue of human 
resource challenges that need to be addressed by the Department of Health. It appears 
from the above statements that there is a serious challenge with regard to the shortage 
of nurses, doctors, pharmacists, social workers, psychologists and general workers. The 
challenges encountered by the above mentioned participants, clearly indicate that there 
is still much to be done on the structural functioning of the whole process of accessing 
antiretroviral treatment. It is also confirmed by the literature below that:  
Gert-Sibande health care system has been characterized by a fragmented and 
inequitable system due to the huge disparities that exist between the public and private 
health care sectors with regard to the availability of financial and human resources, 
accessibility and delivery of health services. This implies that there are negative effect in 
terms of antiretroviral treatment accessibility (Ermelo Provincial Hospital Strategic Plan 
2014:17).  
Karim and Karim (2010:503) argued that, suitable infrastructure is needed to manage 
HIV-infected individuals at primary care level, but funding is not readily available and 
qualified health care personnel are in short supply. Private health care attracts most 
health care funding, but is accessed by less than 20% of South Africans. This is 
evidenced by the number of people on antiretroviral treatment at the public health care 
facilities. 
It can be concluded that the efficiency of the wellness programme in this health care 
facility need to be evaluated. There seems to be challenges that range from human 
capacity, adequate resources and tailor made campaigns aimed at encouraging people 
who were previously on the wellness programme. People living with HIV and who are 
defaulting from antiretroviral treatment needs special encouragement in the form of HIV 
and AIDS awareness. 
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4.4.3 Theme 3: The situation for the past three months in relation to the 
accessibility of antiretroviral treatment. 
Participant 1 
“Treatment isahamba kahle” 
 Antiretroviral treatment is still going well.  
Participant 2 
“Ku sese right for mina” 
It is still right for me 
 Participant 3 
“Mina ngisese right angina nkinga” 
I am still fine and I don‟t have any challenges. 
Participant 4 
“Angikaze ngibe nenkinga”……beku right bengana nkinga ” 
I have never experienced any challenges and the situation was fine.  
Participant 5 
“Mina ngibona isimo sihle azange ngihlangabezane nenkinga” 
I felt that the situation was good and I have never experienced any challenges.  
Participant 6 
“Bengi wathola angikaze ngibe nenkinga”. 
I was accessing antiretroviral treatment and I have never had any challenges. 
Participant 7 
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“No angikaze ngibe nenkinga”. 
No I have never experienced any challenges. 
Participant 8 
“Qha! angikaze ngidilindiswe kodwa inkinga isemzimbeni wami, basho igciwane 
liyakhuphuka”. 
I have never been delayed but the challenge is, I was told that my viral load was 
increasing in my body.  
Participant 9 
“They were accessible, except the delays at the reception area”. 
Participant 10 
“Isimo sona si right”. 
The situation was good. 
Participant 11 
“Ngiyacala ukuthatha  I treatment la ePiet Retief isimo besikahle bekungana nkinga”. 
This is for the first time receiving antiretroviral treatment at this facility.The situation in 
Piet Retief where I was receiving antiretroviral treatment, the situation was fine and 
there were no challenges. 
 
Participant 12 
“Simo si right” 
The situation was good. 
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Participant3 
“Simo besikahle” 
The situation was good. 
Participant 14 
“Ayikho inkinga”. 
There is no challenge. 
Participant 15 
“Kimi beyi right”. 
For me it was good. 
Participant 18 
“I never had any problems except delays”. “But now I have changed strategies, I no 
longer come in the morning because of the delays”. 
Participant 19 
“Mina bengihlala ngiwathola”. 
I always used to get antiretroviral treatment.  
Participant 20 
“Ya! wona bewatholakala amaphilisi”. 
Yes antiretroviral treatment was always accessible. 
Participant 21 
“Ngiyawathola amaphilisi kodwa inkinga iyi one, bangishintshele amaphilisi amanye se 
banginiga leli eli one”. 
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I didn‟t have any challenge in accessing antiretroviral treatment. The only challenge that 
I have experienced is the change of the prescription from the multi-pills to a single dose.   
Participant 22 
“Mina ngiyacala ukuthatha amaphilisi lana”. 
For me, this is for the first time receiving the antiretroviral treatment at this facility. 
 
Twenty (20) participants indicated that accessibility for the past three months has been 
good and they never encounter any problems. It is very clear that the Department of 
Health is doing well in procuring and availing antiretroviral treatment to the multitudes of 
people on treatment in this facility.  The twenty (20) participants also indicated that the 
accessibility of antiretroviral treatment has been good and it can be concluded that 
generally there is no problem interms of access to antiretroviral treatment at the health 
care facility. This refutes the statement in the literature (see Chapter 2) to the effect that  
in many countries access to drugs and other material inputs needed for effective care of 
those living with AIDS-related illnesses are generally not available for reasons often of 
resource constrains. In South Africa, the response of government in general has been 
to argue that there are budgetary constraints limiting access to antiretroviral treatment, 
and that these constraints seem to continue for the foreseeable future (Poku 2005:131). 
Responses from the twenty (20) participants clearly refute such claim and contrary to 
that, participants clearly indicated their gratitude as far as access to antiretroviral 
treatment is concerned. The participants‟ responses also confirm or attest to responses 
made from Theme 1 with regard to the capabilities of Gert-Sibande public health care 
facilities in providing antiretroviral treatment. 
This clearly confirms that participants acknowledge the significance of accessing 
antiretroviral treatment in the public health care facilities and the pivotal role that is 
played by antiretroviral treatment.  
Adherence to antiretroviral treatment, for example, is seen as a safer behaviour in 
delaying the progression of the HIV into a fully-blown AIDS in human body. If a person 
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is aware that adhering to medication will bring positive changes in his/her state of health 
then that person is likely to adhere to antiretroviral treatment. But if a person is not well 
aware of the implications of adhering to antiretroviral treatment and the direct 
consequences of such behaviour, such a person is likely to ignore the commitment of 
taking such treatment and therefore that might lead to defaulting (Van Dyk 2008:122). 
 
The above statements clearly show that participants have been committing themselves 
in coming for antiretroviral treatment on a consistent basis. 
The other three (3) participants had different opinions. Participant 16 indicated that she 
stopped taking treatment in 2014 and she has just come back to re-start the 
antiretroviral treatment, whereas participant 17 and 23 indicated that they have been 
accessing antiretroviral treatment but completely unhappy about the negative attitude of 
the staff members. 
Participant 16 
“Mina ngike ngasitopa ukuthatha amaphilisi ngo 2014 September manje sengibona e 
weight yami  idropper kakhulu”. 
I stopped taking antiretroviral treatment in September 2014 and I realized that I was 
losing a lot of weight.  
Participant 17 
“Be si right, kodwa banoku sebenza mabathanda”. 
The situation was good, but they (nurses) work whenever they like. 
 
Participant 23 
“Baya bheda”. Ba lazy abasebenzi bala. Aba treat umuntu kahle”. 
They are pathetic. Workers here are lazy and they don‟t treat people well. 
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The three participants hold different sentiments but in the context of their comments 
they don‟t indicate inaccessibility of the antiretroviral treatment at the health care facility. 
They only indicate the negative experience they received from the nurses. The same 
applies to participant 16 who also had an argument with one of the nurses at the clinic 
where she was receiving antiretroviral treatment, and that argument resulted in her 
stopping from coming to the clinic as from 2014 until  the date of the interview. 
 
It can also be concluded that all participants were fully aware of the significance of 
receiving antiretroviral treatment, and the consequences of not taking antiretroviral 
treatment. It can be concluded, therefore, that there were no challenges in accessing 
treatment at the public health care facility. Antiretroviral treatment has always been 
available to people living with HIV at the public health care facilities.  
 
4.4.4 Theme 4: Experiences in relation to antiretroviral treatment 
 
Twenty (20) participants emphasized the fact that the accessibility of antiretroviral 
treatment played a significant role in ensuring a better health for them. The situation at 
the facility is good except the delays and the negative attitudes of some staff members.  
There seems to be consistent perception in terms of access to antiretroviral treatment at 
the health care facilities and structural challenges were highlighted in this regard. 
 
Participant 1 
 
“Mina since ngizala esibedhlela angikaze ngibe nenkinga”. 
 
Since I have been coming at this hospital I never encountered any challenge. 
 
Participant 2 
 
“I government mina ngiyayibonga ngoba ngabe angisaphila”. 
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I am grateful for the government for helping me, otherwise I could have been dead by 
now. 
 
Participant 3 
“Sengine sikhathi ngoba sengi right mara ngizophinda ngiwalande amaphilisi”. 
 
It has been a while now since I have been coming for antiretroviral treatment; however I 
will keep on returning to collect more pills. 
 
Participant 4 
 
“Amaphilisi ayaphuzeka awana nkinga”. 
 
The pills are easy to swallow and they don‟t give me any challenges. 
 
 Participant 5 
 
“Kubalulekile ngoba ngesinye isikhathi ngabuyela phansi ngagula futhi”. 
 
It is very important because at some point my health deteriorated and I fell sick again. 
 
Participant 6 
 
“Inkinga ukulinda one hour or two hours mara ekugcineni ayatholakala amaphilisi”. 
 
The problem is waiting to be assisted for about one hour or two hours eventually the 
antiretroviral treatment is available. 
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Participant 7 
 
“Last year ngike ngachekha bangitshela  ukhuthi ngizo thatha amaphilisi ngathi 
bayangihlolela ngabese ngacala ngagula,ngabese ngiyeza ngizothatha amaphilisi”. 
 
Last year I got tested and I was advised to come for antiretroviral treatment. I was in 
denial until the point where I started getting sick that is when I decided to come for 
treatment. 
 
Participant 8 
 
“Ngifundile ukuthi isibedlela siyanakekela kakhulu ngoba mabengiya kodokotela 
bengizo badala ngani. Abasebenzi bala ba sweet”. 
 
I have learned that the hospital is taking good care of me. I was not going to afford the 
fees for the private doctor. Generally workers here are so sweet.  
 
 
Participant 9 
 
“There are no issues about experiences because the improvement is great”. “The only 
thing nne ele reaction ya maoto nne a ruruga”.Mara improvement yona is good”. 
 
There are no issues about experiences because the improvement is great. The only 
thing was the swelling of the legs and the reaction. Legs were swelling but now there is 
a huge improvement. 
 
 
 
 
Participant 10 
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“Nedi ikhona lento engingayi thandi,  lento yokuthi bayasimuvisa, hambe uye clinic 
uhambe uye kuphi kuphi,uthole ukuthi mina angifuni ukuya e clinic, ene masebathi 
hamba vele ufanele uhambe”. “Mina i Clinic angiyifuni”. 
 
There is only one thing bothering me. The thing of referring us to the clinics, I don‟t like 
it.  
 
Participant 11 
 
“Futhi ngifunde kuthi mangithole isikhathi ngizi vocavoce, ngidle healthy kuze kuzo 
assistana nala maphilisi”. 
 
I have learned that whenever I have time I must take care of myself by exercising and 
eat healthy food so that my treatment can become effective. 
 
Participant 12 
 
“Ngifunde ukuthi wona abalulekile ukuthi ngasonke isikhathi uwalande unga yeqhisi”. 
I have learned that it is very much important to get antiretroviral treatment without 
defaulting. 
Participant 13 
 
“Bafanele basimukele bangathathi ukuthi mawuphuza amaphilisi kusho ukuthi ikhanda 
lakho alisebenzi”. 
 
They must accept us the way we are, it does not mean that if we are on antiretroviral 
treatment, that does not mean that we are mentally retarded. 
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Participant 14 
 
“Uma ungena la ngaphakhathi i patient kufanele ibe one kungabe nomunye umuntu”. 
Ngesinye isikhathi uthola aba ngani babo sister sebangaphakathi bese bayaxoxa”. “ 
Abanye bonoku  hambisa I  information yakho ngaphandle”. 
 
When a patient is in the consultation room, there must not be any unauthorized person. 
There were challenges that nurses‟ friends were often allowed to come in the 
consultation room and some of them took the information to the local community. 
 
Participant 15 
 
“I sase right kwa manje angazi ekuhambeni kwesikhathi”. 
 
It is still good for now, and I don‟t know what will happen when time goes on or in the 
future. 
 
Participant 16 
“Umehluko ukhona ngoba i weight yami yehlile kusuka ku 83 kilograms kufika ku 77 
kilograms amaphilisi wona ayanceda”. 
 
There is a huge difference because my weight initially dropped from 83 kilograms to 77 
kilograms; therefore, antiretroviral treatment really helps. 
Participant 17 
 
“Mina angijabule ngalendlela le abasiphathaku ngakhona” 
 
I am happy the way we are treated. 
 
Participant 18 
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“The accessibility is not a problem I always get my medication and I don‟t have any 
problem. They offer counseling before starting treatment”. 
 
Participant 19 
 
“La maphilisi lawo ayangilulamisa angiphatha kahle”.Amaphilisi angi ncende ka khulu”. 
 
The treatment improved my health condition and has assisted me a lot. 
 
Participant 20 
 
“Ngezinye izikhathi basinika I ncwadi ukuthi sithole amaphilisi kuma clinic ene kuyafana 
nala esibhedlela” 
 
In some instances they give us a letter to collect our antiretroviral treatment at the 
nearest clinic.  The situation is similar to the one here at the hospital. 
 
Participants 1 to 20 indicated that their experiences in relation to antiretroviral treatment 
are good based on the fact that the treatment improved their health condition 
significantly. They acknowledge in full the significance of accessing antiretroviral 
treatment. The twenty (20) participants clearly indicated their awareness of adhering to 
antiretroviral treatment. 
 
Similar perceptions were also expressed by the other three participants 21, 22 and 23 
emphasized much on how they are treated when coming for treatment and not on the 
significance of taking antiretroviral treatment. Participant 20 indicated that she is not 
happy about being referred to the clinic due to the fact that at the clinics the service is 
very much poor. She indicated that she preferred the hospital than at the clinic due to 
the poor service rendered by the clinics. Participant 21 indicated lack of social support 
as a very serious problem. The participant is only 19 years old and lost all his parents 
due to AIDS related diseases and who got infected through mother-to-child 
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transmission. Participant 22 indicated that it is normal to get queues at any public health 
care facility and he is fine with the manner in which treatment is provided to him. 
 
It is evident from the views of all participants that their experiences regarding 
antiretroviral treatment are generally good. The areas that need to be improved are the 
process flow and implementation of the code of conduct from the health personnel. The 
participants perceived the turn-around time as a major challenge that needs to be given 
a serious attention. Their perceptions regarding antiretroviral treatment vary due to the 
fact that some participants takes a single dose while the other participants take multi-
dose. Participants had different views regarding new antiretroviral treatment and their 
views vary from one participant to the other. Generally, a single dose pill is seen as a 
relief to those participants who feel very uncomfortable in taking multiple pills. 
 
4.4.5 Theme 5: Overall experiences about the accessibility of the antiretroviral 
treatment. 
 
Participant 1 
 
“Mina bayangiletha abelungu bami la esibhedlela”. “Mina sengihola i 
pension.Bangitshelile ukuthi  imithi singayithola nasemakhemisi”. 
My employers transport me to the hospital. I am currently receiving social grant. I was 
informed by the health personnel that antiretroviral treatment can be obtained at the 
pharmacies. 
Participant 2 
 
“Basisizile ngalendaba yokuthi siphuze leli eiliyi one ngoba asisakhohlwi  ukuphuza.Ma 
wazi ukuthi ngiphuza ngo seveni,ngiyazi ukuthi ngaleso sikhathi ngiya liphuza,noma 
ngihamba ngiyali thatha ngilifake kwenyei container ukuthi anganaki loyo muntu”. 
 
They really helped us a lot by introducing a single dose because it is only taken once at 
seven. I know that on the prescribed time I am taking my pill or taking it along with me 
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whenever I am visiting and put it in different container so that the person I am visiting 
should not notice the type of the pill I am taking.  
 
This implies that client-patient confidentiality/privacy could be maintained (Pera and Van 
Tonder 2011). 
 
Participant 4 
 
“Kimi ku right angikaze ngibe ne nkinga” 
 
I have never experienced any challenge. 
 
Participant 5 
 
“Akubi nenkinga yonke into i right”. 
 
There is no challenge, everything is good. 
 
Participant 6 
 
“Mina ngiya wathola amaphilisi angikaze ngifike la ngingawatholi”. 
 
I have never experienced any shortage of antiretroviral treatment. 
Participant 7 
 
“Partner yami ayifuni ukuza la esibhedlela, ayifuni kuza ukuzo thatha amaphilisi”.He 
does not want to take treatment and we are having sex without a condom”. 
 
My partner does not want to come to the hospital for treatment. He does not want to 
take treatment and we are having sex without a condom. 
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This implies that there is a need for intensification of health education in relation to 
sexually transmitted diseases that include HIV. 
 
Participant 8 
 
“Mina ngiya jabula ukutholakala kwamaphilisi kulesibhedlela”. 
 
I am happy about the availability of pills (antiretroviral treatment) at this hospital. 
 
Participant 9 
 
“Overall experience is good”. 
 
Participant 10 
 
“Khona ku right indaba mina angifuni i clinic”. Angifuni  ukuthatha amaphilisi e clinic”. 
 
The situation is good but I don‟t like to receive antiretroviral treatment at the clinic.  
 
The participant is of the opinion that receiving antiretroviral treatment at the clinic might 
compromise the integrity of the nurse-patient confidentiality. The clinics are seemed to 
be under resourced in terms of equipment and human resource capacity that might 
hinder professional accessibility of antiretroviral treatment. 
 
Participant 11 
 
“Yonke into ePiet Retief beyihamba kahle”.Beyingekho  inkinka” 
 
Everything was going well at Piet Retief and there were no challenges. 
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Participant 12 
 
“Mina ngifunde ukhuthi wona abalulekile ukuthi ngaleso sikhathi uwalande”. Ngoba 
abaluleke kakhulu”. 
 
I have learnt that the antiretroviral treatment is important and I should go and collect 
them at the prescribed date. 
 
This has showed that participants have a clear understanding about the importance of 
antiretroviral treatment and the follow-up date. 
 
Participant 13 
 
“Kunalento le yokuthi uma uthatha amaphilisi ngathi uyasangana”. Mina ngifuna 
ukuthatha amaphilisi khona la esibhedlela”. 
 
There is this perception that whenever a person is on antiretroviral treatment is mentally 
retarded. I just want to get my antiretroviral treatment at this hospital. 
 
There seems to be a negative perception from the community that, people who are on 
antiretroviral treatment are mentally retarded. There is a need to educate the community 
to accept people living with HIV and who are on antiretroviral treatment. (A further 
research on the impact of antiretroviral treatment with regard to mental retardation 
should be conducted). 
 
Participant 14 
 
“Mina ngicela ba increaze bo dokotela ku wellness ngoba ku sebenza u dokotela oyi 
one”. 
I just request an increase in the number of doctors at the wellness section because only 
one doctor is working there. 
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Participant 15 
 
“I experience yami yokuthatha amaphilisi i sase right okwamanje ne staff si right” 
 
My experience of getting antiretroviral treatment is still good for now and the staff is also 
good. 
 
Participant 16 
 
“Amaphilisi aletha umehluko, bengidla kahle before ngi defaulter.Mina ngifuna abo 
nurse basiphathe kahle”. 
 
Antiretroviral treatment brings so much improvement, I was in good health before I 
defaulted, and I just pledge that nurses must treat us well. 
 
This implies that participants on wellness program must be encouraged not to stop 
antiretroviral treatment by health care personnel. Nurses must always portray positive 
attitudes towards their clients/patients. 
 
Participant 17 
 
“Angifuni ukuya e clinic.E clinic lento eyenza ukuthi ngingafuni iloko ukuma ngaphandle 
uphinde uyoma ngaphakhathi, uthethiswe yonke lento”. 
 
I don‟t want to go to the clinic because you will be told to queue outside and when you 
get inside they shout at you. 
 
There seems to be a challenge of service delivery at the clinic, therefore, the researcher 
is kindly requesting the intervention from Mpumalanga Department of Health. The 
intervention might be in the form of staff training on the Batho Pele Principles, ethical 
conduct and client orientation and customer focus.  
71 
 
Participant 18 
 
“The service needs to be improved especially at the reception area. But in terms of 
access to antiretroviral treatment everything is good”. 
 
The participants seem not to be satisfied about the service at the reception area. There 
is a need to address those challenges in order to improve comprehensive health service 
delivery. 
 
Participant 19 
 
“Avikela umzimba wami”.Bengigula mina before ngicala ukuthatha amaphilisi”. 
 
Antiretroviral treatment protects my body and I was very sick before I commenced  
treatment.  
 
Participant 20 
 
“Bo nurse bala bafanele bathathe i lunch ngoku shiyana bangayithathi  ngesikhathi esiyi 
one”. 
 
Nurses should not take lunch at the same time; they must rotate their lunch times. 
 
The nurses „attitude need to be re-oriented from a negative to a positive attitude. The 
Nursing Service Manager of the hospital should make sure that their subordinates are 
handling members of the community in dignified manner. 
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Participant 21 
 
“Mina ngike nga defaulter isikhathi eside, amaphilisi lawo bangiphawo wona manje 
awana power”. 
 
I defaulted for a long period of time and I have noticed that the antiretroviral treatment 
that I am receiving now does not have power. 
 
There seems to be a need for further research on the effect of antiretroviral treatment 
on people living with HIV and got infected through Mother-to-Child transmission. 
 
Participant 22 
 
“Mina ngasho ngathi ikahle angikhomplaini, ngaphandle nje ukuthi kuba slower nyana”. 
 
All I can say is that I don‟t have any complain except from the fact that they are bit 
slower sometimes. 
 
Participant 23 
 
“Ku right ngingasho ngithi i place yabo e right”. 
The place is generally good. 
 
It is clear that participants are generally happy about getting treatment at the hospital 
and they also indicated some discomfort in taking their antiretroviral treatment at the 
nearby clinics. Participants are happy about receiving their treatment on regular basis 
and also indicated that they never encountered any problems in relation to the non-
availability of the antiretroviral treatment. Participants are generally happy about the 
introduction of a single dose antiretroviral pill which is viewed as easy to take and is 
taken once a day. It is viewed by participant 2 as very encouraging and easy to take. 
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A researcher has noted that other participants hold different views regarding their 
overall experience in coming for treatment. Some participants indicated that there are 
areas that need to be improved and those areas are not limited to structural functioning 
of the program, but also to staff or personnel way of rendering service. That view can be 
confirmed by expression from participant 20, that nurses need to rotate their lunch 
times. Participant 20 suggested that the wellness programme must operate throughout 
the day and nurses lunch times need to be well coordinated so that when one nurse 
goes on lunch the other one can remain rendering service at the wellness center. 
 All participants are generally aware of the significant of taking antiretroviral treatment. 
The latter statement can be confirmed by the views expressed by participant 19. 
 
The overall experience about the accessibility of the antiretroviral treatment in public 
health care facility is good. The waiting period at the reception and the negative 
attitudes of the nurses need to be addressed. 
 
4.4.6 Theme 6: Effect by the availability and non-availability of the antiretroviral 
treatment. 
 
Participants‟ views regarding their feelings when accessing treatment with special focus 
on the availability of antiretroviral treatment and the non-availability of the antiretroviral 
treatment in public health care facility. The participants‟ perception towards antiretroviral 
treatment and its significance were explored in this section. 
 
Participant 1 
“Kungiphatha kahle Ukutholakala kwamaphilisi” 
The accessibility of antiretroviral treatment is very good. 
 
Participant 2 
 
“Ngaphatheka kabi”. 
I will feel bad 
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Participant 3 
 
“Mina ngaphatheka kahle ngobangizokwenza  njani”. 
I will feel fine because there is nothing I can do. 
Participant 4 
“Kungangiphatha kabi ngoba mangifikile ngingawatholi angeke phela kulunge njalo”. 
I will feel very bad because there is nothing that will be better under those conditions. 
Participant 5 
 
“Bafanele bangichazele ukuthi uma aphelile aphele njani”. 
They have to explain when the antiretroviral treatment is not available. 
Participant 6 
 
“Yoo! angeke ngibe right ngoba ngifanele ngiphuze everyday,yaa….. ngeke ngibe right. 
 
I won‟t feel good because I have to take the pills (antiretroviral treatment) every day. 
 
Participant 7 
 
“Ku ngiphatha kahle”. 
The situation is good. 
Participant 8 
 
“Kungangi limaza loku ngoba nje ngala maphilisi lawo ngiwadlako abaluleke kakhulu 
kabi empilweni yami”. 
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It can hurt me because the pills (antiretroviral treatment) that I am taking are playing a 
important role in my life. 
 
Participant 9 
 
“That will be a disaster, a very bad thing to happen”. I don‟t wish that to happen”. 
Participant 10 
 
“Phela ngingaphatheka kabi, ngizokwenze njani if angiwatholi”. 
 
I will really feel bad if I don‟t get the antiretroviral treatment at the hospital. 
 
Participant 11 
 
“Kungangiphatha kabi ngempela ukuthi inkinga kuzabe kuse i viral load se iba phezulu 
a masosha ami awasakhoni ukuthi alwenayo ngalendlela e lamele”. 
I will feel very bad if I find the medication not available because the viral load will rise 
and my immune system will be unable to deal with the virus. 
 
Participant 12 
 
“Ngeke ngiphatheke kahle”.Ngizo phatheka kabuhlungu”. 
 
I won‟t feel good if I don‟t get treatment. I will be hurt by the non-availability of the 
antiretroviral treatment. 
 
Participant 13 
 
“Ngaphatheka kabuhlungu ngoba i mpilo yami angkeke ngiphile ngaphandle kwawo”. 
76 
 
 
I will really feel bad because it is my life, and i won‟t survive without the antiretroviral 
treatment. 
 
Participant 14 
 
“Kungaba kabi mara mangithole I message ukuthi aphelile ngizo mukela”. 
 
I will feel bad but if I get a message that the antiretroviral treatment is finished I will just 
accept. 
 
Participant 15 
 
“Abaluleke kakhulu”. 
 
The antiretroviral treatment is very much important.  
 
Participant 16 
 
“Amaphilisi uma atholakala ngiphatheka kahle”. Kuno bungozi phakhathi uma 
ongawathathi njengoba i weight yami be  yehla”. 
 
When pills (antiretroviral treatment) are accessible and available I feel good. There is a 
danger when one does not take them because my weight dropped a lot. 
 
Participant 17 
 
“Mina ngizo kwenza njani umabathi aphelile ngoba ngophila ngawo”. 
 
I don‟t know what I can do if I am told that the pills (antiretroviral treatment) are finished 
because I survive because of them. 
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Participant 18 
 
“It will be a problem because I am supposed to take medication on daily basis. So I am 
always impressed by the service rendered here”. 
 
Participant 19 
 
“Nda phatheka kabuhlungu”. “Mabangitshela ukhuthi aphelile”. 
 
I will feel bad if I am informed that the antiretroviral treatment is finished. 
 
Participant 20 
 
“Kungaba buhlungu masingathola ukuthi awekho”. 
 
I will feel pain if I am told that the antiretroviral treatment is finished. 
 
Participant 21 
 
“Mina angisana ndaba ukhuthi ngiyawathola or angiwatholi,mina nje ngilinde ukufa”. 
 
I don‟t care whether I access them or not the only thing that I am waiting for is to die. 
 
Participant 22 
 
“Ngeke ngiphatheke kahle if angiwatholi ngoba abalulekile kakhulu emzimbeni wami”. 
 
I won‟t feel good because antiretroviral treatment plays a big role in my body. 
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Participant 23 
 
“If angiwatholi nginga phatheka kabuhlungu”. 
If I don‟t get antiretroviral treatment I will feel very bad. 
 
Most participants indicated that the continuous availability of antiretroviral treatment in 
the public health care facility plays an integral part in the improvement of their health 
condition. Participants also pointed out that if ever the situation can change and start 
experiencing shortages in the availability of antiretroviral treatment, they will surely feel 
very disappointed as they have realized over time that taking antiretroviral treatment 
actually improved their health conditions. 
That can be confirmed by the health belief model that; the perceived benefits of an 
action where the proposed action is effective in reducing the health risk will likely 
encourage consistency in that particular action. The course of getting antiretroviral 
treatment has the health benefits such as improvement of health condition and the 
reduction of opportunistic diseases (Chirambo & Ceasar 2003). 
It is evident from the above views expressed by participants that they are fully aware of 
the health benefits that are brought by taking antiretroviral treatment. Only participant 21 
indicated that he does not care whether he access treatment or not .Participant 21 
indicated that he is actually waiting to die and that is also confirmed by his admission 
that he has been defaulting numerous times.  
The researcher‟s recommendations will be discussed in Chapter 5 where key findings of 
the study will also be outlined. 
4.5 Conclusion 
This chapter presented the key findings of the research based on the research purpose 
and objectives and provided evidence for each of the research questions, as well as a 
basis on which to apply selected theory: Health Belief Theory. 
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Participants‟ views where expressed regarding the following: the capabilities of Gert-
Sibande public health care facilities in providing antiretroviral treatment. The measures 
to improve the accessibility of antiretroviral treatment in Gert-Sibande public health care 
facilities. The situation with regard to accessibility of antiretroviral treatment for the past 
three months. The participants experience in relation to antiretroviral medication when 
receiving treatment. The participants‟ experiences in relation to accessibility of 
antiretroviral treatment. The effect on participants of the availability or the non-
availability of antiretroviral treatment in the public health care facility. 
The next chapter draws an overall conclusion of the study so as to make 
recommendations. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
80 
 
CHAPTER FIVE 
CONCLUSIONS AND RECOMMENDATIONS 
 
5.1 Introduction 
The aim of this study explored the accessibility of antiretroviral treatment amongst 
people living with HIV and AIDS at Public Health Care Facilities in the Gert-Sibande 
region in Mpumalanga and how people taking antiretroviral treatment in the public 
health care facility experience when coming for treatment. The study aimed at exploring 
understanding in relation to accessibility of antiretroviral treatment amongst people 
living with HIV at Gert-Sibande Public Health Care facilities in Mpumalanga Province. 
To achieve this purpose, a qualitative research methodology was chosen based on the 
literature and the applicable theory to motivate an explorative research design. 
5.2 Summary of Findings 
The following were found on the exploration of accessibility of antiretroviral treatment 
amongst people living with HIV and AIDS at Public Health Care facilities in Gert-
Sibande region in Mpumalanga. 
5.2.1 The capabilities of Gert-Sibande public health care facilities in providing 
antiretroviral treatment.  
5.2.1.1 Structural problems in accessing antiretroviral treatment 
All twenty-three (23) participants found that they access antiretroviral treatment 
flawlessly and are happy about the availability of antiretroviral treatment at the public 
health care facilities and none of the participant ever mentioned any experience relating 
to shortage of antiretroviral treatment. 
All the participants indicated that they are happy about the un-interrupted supply of 
antiretroviral treatment and confirmed their wishes of getting treatment whenever they 
need it. It is evident from the participants‟ responses that antiretroviral treatment is 
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easily accessible at Ermelo Regional Hospital where research took place and through 
the response from certain participants, who were taking treatment from Piet Retief 
Hospital, expressed the similar experiences by mentioning that also at Piet Retief 
Hospital there were no problems in accessing antiretroviral treatment. 
The views expressed by participants support the theoretical empiricism of the Health 
Belief Model which emphasises behavioural modification  as a very important aspect in 
risk reduction in the fight against the scourge of HIV and AIDS (Manique 2004:88). 
The efforts by participants to come for treatment showed that psychologically they are 
aware of the danger for not coming for the treatment, and the threat posed by failure to 
take antiretroviral treatment. Although some participants indicated that they have 
defaulted at some point while taking treatment, the fact that they are now back on 
treatment really indicate that they are fully aware of their susceptibility to opportunistic 
diseases whenever they are not taking treatment. Participants are aware of the 
perceived susceptibility and perceived severity of health conditions (Manique 2004:87). 
Participants who were defaulting are back on treatment and this is evident that 
antiretroviral treatment is playing a significant part in improving the health conditions. All 
participants shared similar views in relation to access to treatment. The participant only 
mentioned the delays caused by administration of files, as a delaying factor in 
accessing treatment and suggested that, if administration of files can be done at the 
wellness center that can assist in speeding up the process of accessing treatment. The 
other challenge pointed out by most participants is the issue of referral to the local 
clinics. Most participants didn‟t like the fact that when their conditions are getting better, 
they are often referred to the nearby clinics to get their antiretroviral treatment.  
Participants pointed out that there are so many delays at the clinic than at the hospital 
and the fact that queues are very long at the clinics is a nightmare for them. The 
participants often pointed out that the nurses‟ negative attitudes at the clinics is very bad 
and discourages them from going to the clinics. According to Squire (2007:42) for a full-
functional roll-out programme to be successful there should be human capacity. Human 
capacity development takes precedence over capital allocation.  
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This view is supported by participants who mentioning that there is only one doctor 
working at the wellness centre. It is also reported by participants that nurses sometimes 
take lunch at the same time and thus causes unnecessary delays in receiving 
treatment. 
Administration of files and the capacitation of the existing personnel are critical areas for 
improvement.  
 
5.2.2 Things to be done to improve the accessibility of antiretroviral treatment in 
Gert-Sibande public health care facilities. 
There were different opinions regarding things that can be done to improve the 
accessibility of antiretroviral treatment in Gert-Sibande public health care facilities. 
Despite the fact that participants most of them were aware of the hospital‟s Central 
Chronic Medicine Distribution and Dispensing Programme (CCMDD), it became clear 
that participants feel comfortable to receive their antiretroviral treatment at the hospital 
rather than at the designated private pharmacies. 
The Central Chronic Medicine Distribution and Dispensing Programme (CCMDD) is an 
alternative chronic medication access programme for the public sector patients at the 
nearest pick up points to their homes or place of work. The approach seeks to relieve 
health facilities of the increased number of patient visits. The programme aimed to 
improve supply of medication to stable chronic patients outside the facilities at points 
easily accessible to them. The Department of Health realized that the public health care 
facilities handle unnecessary repeat visits of stable patients, the administrative duties 
are often neglected leading to overcrowding, high head counts, long waiting times, 
negative staff attitudes due to work overload, occasional shortage of medicines and 
complaints from clients about non-availability of medicine (Department of Health 
2016:2). 
Participants were aware of the existence of the (CCMDD) but indicated that they don‟t 
feel comfortable receiving their medication at the private pharmacies despite the fact 
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that they are health condition is stable. It has been indicated that patients who are 
stable are also often referred to the nearest clinics to get their medication there, but 
participants indicated that they don‟t like going to the clinics due to either long queues or 
staff‟s negative attitudes at the nearest clinics. 
Eight participants indicated that they are happy about the current system of providing 
antiretroviral treatment, when asked about what can be done to improve the current 
system of accessing antiretroviral treatment. These participants also mentioned that 
they have never experienced shortage of antiretroviral treatment in the facility. 
Six participants indicated that the reception area / administration system of the files 
need to be improved. They emphasized that they spend long waiting time at the 
reception area either, the file cannot be located and a skeleton (temporary) is instead 
opened. This is a prevalent norm at the reception area of the hospital according to the 
six participants. It has also been suggested by one participant that there should be 
someone appointed to receive first time patients in terms of informing them about the 
process flow at the reception area just like at the banks where people are directed 
according to their required services. Another participant suggested that the filing system 
of people living with HIV should be integrated with the wellness programme, meaning 
that those living with HIV should not queue at the reception area. It is suggested that 
they must just come directly at the wellness centre and receive their medication there. 
Three participants suggested that there must be more additional staff members at the 
wellness centre. Additional doctors were also suggested by one participant to assist the 
rising volumes of people on antiretroviral treatment. One participant further suggested 
that the nurses at the wellness centre should coordinate their lunch time so that the 
service delivery is not affected. The participants also noted that during lunch time all 
nurses who work at the wellness centre go on lunch and the wellness centre is closed 
for that duration and that causes unnecessary delays. 
Another three participants indicated that they had defaulted and that ranges from 
varying reasons such as; lack of social support from the government in terms of the 
provision of social grants and food parcels to supplement their required diet of a patient 
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on antiretroviral treatment. Another participant‟s reason for defaulting was based on the 
much improved health condition. He indicated that since he started taking treatment 
there was a huge improvement in his health condition to a point where he thought it is 
no longer necessary to take antiretroviral treatment therefore he decided to default. Now 
he realized that his health condition has deteriorated due to the fact that he stopped 
taking treatment and decided to come back for treatment again. The third participant‟s 
reason for defaulting was based primarily on the nurses‟ negative attitude at the clinic 
where she was taking treatment. She decided to come to the hospital to access her 
antiretroviral treatment. She indicated that since she stopped taking her treatment her 
weight dropped dramatically. The participant indicated that she was weighing around 83 
kilograms before defaulting and now she weighs 77 kilograms. The latter statement is 
also supported by Smith (2013:262) that, HIV treatment suppresses viral load and 
infectiousness and improves health status, and the counseling and other medical care 
that comes with treatment which normally accompanied by a decrease in sexual risk 
behaviour. 
It is therefore suggested by the researcher that programmes aimed at encouraging 
people living with HIV who have defaulted to come for treatment again. It is evident from 
the participants‟ views that there are still a lot of people who were on treatment and for 
various reasons decided to stop taking treatment. Social mobilization programme 
should be initiated to encourage those who have defaulted to come forward and be re-
registered in the antiretroviral treatment programme. 
Two participants suggested differently on the subject matter. One participant indicated 
that dates should be coordinated due to the fact that he is having a lot of antiretroviral 
treatment in access. He pointed to the fact that dates are very close to each other 
therefore when he goes for treatment he finds that  he still has a lot of pills in his 
possession. Another participant highlighted the introduction of the CCMDD as 
something that will definitely improve the patient service and the extension of operating 
hours is highly recommended. 
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One participant pointed out that, it was for the first time for him coming for treatment, 
therefore, he cannot suggest nor have an opinion about improvement of service in 
relation to accessibility of antiretroviral treatment. 
Concluding the views of participants „s suggestions on the improvement of the 
accessibility of antiretroviral treatment in Gert-Sibande public health care facilities, the 
health belief theory validates participants‟ views that perceptions of reality, rather than 
objective reality, influence behavior. The importance of the consequences of behavior in 
predicting actions, while cognitive theory modified this by stressing the relevance of the 
person‟s subjective valuations, and their judgment of the likelihood that an action would 
have desired consequences. In this theory, health behaviors are influenced by a 
person‟s desire to avoid illness or to get well, and by their confidence that the 
recommended action will achieve this (Janz et.al 2002). 
 
5.2.3 The situation for the past three months in relation to the accessibility of 
antiretroviral treatment. 
Twenty one (21) participants indicated that there has been a consistent accessibility of 
antiretroviral treatment for the past three months. Two participants had different views.   
One participant (1) indicated that he does not know about the situation for the past three 
months as he has just commenced treatment on the day of the interview. Another 
participant indicated that the situation at the hospital has been very bad. He further 
elaborated by indicating that the staff is lazy, he is not treated very well. But other than 
what he already mentioned, it becomes clear that he gets his treatment consistently. It 
can also be highlighted that the consistent accessibility of antiretroviral treatment is not 
only limited to Ermelo Provincial Hospital, but also to Piet Retief hospital as one 
participant indicated in his comment that he was taking medication in Piet Retief and he 
never encountered any problems in relation to availability of antiretroviral treatment. 
The above views of participant clearly refute the initial claims from the literature review 
(Chapter 2) that, there are still challenges of scaling up HIV treatment programs in 
Africa (2005:124).It is evident from the views expressed by participants that the 
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provision of antiretroviral treatment in public health care facilities in Gert-Sibande is  
good. 
 
5.2.4 Experiences in relation to antiretroviral treatment. 
Various perceptions were expressed by all twenty three participants in relation to their 
experiences of antiretroviral treatment. 
Fifteen (15) participants acknowledged the role that is played by antiretroviral treatment 
in improving their health conditions. Their experience ranges from recovering from 
weight loss, to the improvement in their health conditions. Some participant 
acknowledge the complications that come with taking antiretroviral treatment but 
however indicated that once one get used to taking treatment the situation improves 
each day. The significance of antiretroviral treatment cannot be over emphasized; their 
main functions have been explained in detail in (see Chapter 2). 
Smith (2013: x) indicated that recent scientific breakthroughs suggesting that treatment 
is also a highly effective form of prevention. It is very clear that participants understood 
the significance of accessing treatment and those who had relapses have come forward 
to seek assistance at the public health care facilities. 
Eight (8) participants expressed different views and their responses vary according to 
what they have experienced. Some participants named the fact that they are often 
referred to the clinics and they don‟t feel comfortable in taking their treatment at the 
nearby clinics. Despite the CCMDD‟s clear objectives, participants do not like the idea 
of being referred to the local clinics even when their health conditions have been 
normalized or stabilized. Other participants complained about the waiting period before 
being assisted by the staff. The issue of lack of privacy was also highlighted by one 
participant. Participant indicated that sometimes some staff members such as cleaners 
or other members who are not working at the wellness are sometimes present in the 
consultation room and therefore patient „s confidentiality is often compromised. 
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 It is validated by Van Dyk (2008:430-438) that, people living with HIV have the right to 
confidentiality and privacy about their health and HIV status. It is further argued that 
South African courts have recognized that confidentiality and privacy regarding HIV 
status extends to health care colleagues.  
The issue of staff‟s negative attitudes towards patients was also mentioned and their 
work ethics, commitment and passion have been under a lot of criticism from several 
participants. The nurses‟ treatment towards people living with HIV is not good according 
to some participants. The participants‟ further indicated that taking antiretroviral 
treatment is associated with mental retardation by the nurses. This assumption might be 
perpetuated by a scientific evidence that suggest that one of the opportunistic diseases 
associated with HIV is the neurological disorder normally caused by fungal infection in 
the central nervous system or Toxoplasma encephalitis better known as protozoal 
infection of the brain that causes damage to the brain itself (Van Dyk 2008:58). 
One participant indicated that there is lack of social support from the side of 
government. The participant complained that he often takes antiretroviral treatment on 
an empty stomach. Socio-economic situation of the participant was described as very 
poor and the participant got infected through Mother-to-Child transmission and he left 
school due to his poor health and now there is no social grant from the government 
since he turned 18 years of age. The participant indicated that it will be better if he 
receive food parcels from the government. 
Another participant complained about the staff„s negative attitudes at the clinic. Some 
participants indicated that they don‟t want to be referred to the nearest clinics due to 
long queues, poor service and nurses‟ negative attitudes towards them. One participant 
who had defaulted for a year mentioned that there was a reason for stopping treatment. 
The reason for the participant to stop taking treatment is the manner in which she was 
mistreated by the male at a local clinic. She mentioned that the negative attitude of that 
particular nurse contributed negatively towards her defaulting treatment. She further 
elaborated that she started losing weight dramatically and got sick and she decided to 
come back for treatment but this time not at the local clinic where she had an encounter 
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with the nurse, this time she decided to come to the hospital hoping for a better 
treatment. 
 
5.2.5 The overall experience about the accessibility of antiretroviral treatment 
Fourteen (14) participants stated that overall experience about the accessibility of the 
antiretroviral treatment is good. This clearly validated the fact that accessibility of 
antiretroviral treatment in Gert-Sibande public health care facility is good and it must 
also be noted that this cannot be said about the surrounding clinics and other hospitals.  
But the gist of the matter is participants who took part in this study clearly pointed out 
that there is poor service at the surrounding clinics and they don‟t want to be referred to 
the clinics even if their health condition has stabilized as per CCMDD objectives. 
Participants clearly shared the same feeling about the uneven health care delivery 
system between the hospital and the surrounding clinics. Participants also mentioned a 
very fragmented health care delivery system at the clinics which might be influenced by 
various reasons that need to be systematically studied. 
Eight (8) participants expressed different views regarding their overall experience about 
the accessibility of antiretroviral treatment. Some participants mentioned that the 
introduction of a single dose pill is seen as a relief especially to people who are not 
confortable in taking pills. Participants acknowledged the fact that they are fully aware of 
the CCMDD programme and they feel very comfortable to take their treatment at the 
hospital rather than at the private pharmacies. One participant indicated that the private 
pharmacies will bring a lot of relief to the public health care facilities which are always 
overcrowded. Another participant mentioned that it will be a wise move if the hospital 
management can integrate or centralise wellness centre by having its own 
administration, nurses, doctors and its own pharmacy.  
Other participants mentioned that barriers created by the nurses‟ negative attitudes 
should be removed in order to ensure an ameliorated situation for patients without being 
emotionally abused. Some participants mentioned the unequal socio-economic situation 
as a barrier towards effective antiretroviral treatment. Social and economic support was 
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seen as an integral part in ensuring that people on treatment afford adequate food and 
proper shelter. This view is also supported by Karim and Karim (2010:418) asserted that 
economics itself influences the epidemic, as one of the drivers and determinants of the 
scope and the scale of the epidemic. All economic decisions are driven by choice, 
scarcity and uncertainty. 
One (1) participant indicated that it will be proper to answer this question after initiating 
antiretroviral treatment. 
5.2.6 The effect of the availability and non-availability of the antiretroviral 
treatment 
Twenty two (22) participants indicated that if ever they were to visit the hospital and be 
told that the antiretroviral treatment is out of stock they would definitely feel very bad. 
They further elaborated by pointing out that their lives would be at stake should they 
cease to take their antiretroviral treatment on a regular basis. Participants shared the 
same feeling regarding the availability and accessibility of antiretroviral treatment in 
Gert-Sibande health care facility.  
The above statements clearly affirmed their high level of self-efficacy as it has been 
demonstrated in the health belief theory. The participants‟ belief in their self-efficacy 
influenced the choices they made, their aspirations, how much effort they mobilized in a 
given activity, how long they persevered in the face of difficulties and setbacks, whether 
their thought patterns were self-hindering or self-aiding to them (Van Dyk 2008:125). 
It is evident that participants are fully aware of the importance of accessing antiretroviral 
treatment and to persevere against structural obstacles that are existing in the public 
health care facility, this clearly demonstrate their highly developed self-efficacy which is 
always rewarded by the availability of antiretroviral treatment. 
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5.3 Limitations of the study 
The study had the following limitations: 
5.3.1 The role of the researcher 
During the interviews the researcher has noted that most participants continued to 
address him as “ Doctor” despite the fact that he introduced himself clearly as a student 
from the University of South Africa. The participants might have been biased in 
answering certain questions that would have negatively impacted the credibility of the 
health care facility. The researcher was tempted to interview the same participants in a 
different setting, preferably a neutral venue or at their homes where they would have felt 
more comfortable and relaxed. The researcher is of the opinion that the formal 
bureaucratic setting of the hospital might have influenced the rationality of some 
participants who were mostly above forty (40) years of age and/or more. Qualitative 
research implies that data collection should take place within the natural setting, 
however the question that still lingers in the researcher‟s mind is how natural is the 
natural setting? 
During the pilot study three participants were requested to take part in the pilot study to 
test the questions in advance, however, the researcher has noted some differences 
between participants in the pilot study and the ones who took part in the actual study. 
During the pilot study three participants were talking in high pitch voices and seemed to 
be more relaxed than participants in the actual study. These are the reasons why the 
researcher was willing to interview the twenty three (23) participants in a different 
setting or location, preferably at their homes where it is more relaxed than at the 
hospital. 
It has been observed that most of the participants were talking in low pitch voices. It 
seems as if the participants didn‟t want to be overheard by other people such as nurses 
and other personnel within the facility. Despite the fact that the researcher introduced 
himself as a Master‟s student, it became obvious from the reaction of participants that 
they continued perceiving the researcher as part of the hospital personnel. 
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5.3.2 Research site and participants 
The study was conducted at the Ermelo Regional Hospital which falls under Gert-
Sibande region; however the conclusions and recommendations could not be made with 
regard to other public health care facilities in Gert-Sibande but solemnly in regard to 
Ermelo Regional Hospital. The conclusions and recommendations cannot be made in 
regard to the local clinics, but only a further research is recommended at the local 
clinics to establish the state of accessibility of antiretroviral treatment in those facilities. 
Despite a high number of participants indicating that they don‟t want to be referred to 
the clinics due to poor service, one cannot use that information as foregone conclusion 
to suggest that there is a poor service delivery at local clinics. Empirical study need to 
be conducted to establish or refute such claims. 
It was difficult to interview patients who are defaulting and who are no longer coming for 
treatment. It could have been much better if their views and opinions regarding 
accessibility of antiretroviral treatment were documented. The information collected only 
relates to the participants and cannot be generalized to the general people living with 
HIV and AIDS who are on treatment. 
The researcher went into the interview with no preconceived ideas and was motivated 
to explore the accessibility of antiretroviral treatment in Gert-Sibande public health care 
facilities. 
Time of the study was very limited on the part of the researcher and the bureaucratic 
barriers disabled the study to overlap to the three local clinics. 
5.4 Recommendations 
The researcher would like to make the following recommendations based on the 
research findings: 
 The Provincial Department of Health in Mpumalanga has a need to re-look into 
the current Hospital management and administration system especially patients‟ 
files. 
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 Turnaround time at the reception area needs to be taken into consideration for 
the betterment of an efficient and a speedy service delivery. 
 The management needs to explore the possibility of capacitating the hospital 
wellness centre with more staff. 
 Confidentiality and privacy of patients should be maintained at all times by health 
care professionals. Nurses should be advised not to allow their friend and 
colleagues access into the consultation room while they are busy with the 
patients and or clients. 
 All stable patients should be encouraged to continue taking treatment at the 
Hospital until introduced gradually to clinics and private pharmacies. But the 
service delivery challenges at the clinics have to be addressed by the 
Department of Health Mpumalanga Province. 
 The CCMDD programme needs to be properly marketed and effectively 
communicated to all people on chronic treatment to enable them to fully 
understand about its significance. 
 The programmes that are aimed at identifying and encouraging clients, who have 
defaulted or relapsed from taking antiretroviral treatment, should be developed 
and implemented. 
 The management of Ermelo Regional Hospital needs to assess the conditions at 
the three local clinics emphasising more on accessibility of antiretroviral 
treatment. They must also take into cognizance the structural and human 
resource challenges that are faced by the clinics health care personnel. The 
nurses at the clinics need a behavioural change with regard  to their reported 
negative attitudes towards people living with HIV. 
 The Department of Social Development needs to be reminded about their 
constitutional obligations and clear mandates bestowed on them in relation to 
socio-economic conditions of some patients on antiretroviral treatment, who does 
not access social grant and who are eligible to receive it. Policies on social grant 
needs to be revisited in terms of people living with HIV. The concern was 
revealed by participants living with HIV, who were receiving social grant before 
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the age of eighteen 18 years  but the grant got terminated according to 
government policy on social grant, leaving them with a socio-economic burden   
 The political statement that was issued by the National Minister of the 
Department of Health in relation to accessibility of antiretroviral treatment of all 
HIV positive patients regardless of their CD4 count needs to be critically 
scrutinised. The success of this bold stand or statement by the Minister can only 
be a reality provided that all vacant posts within the Department of Health 
institutions are filled with the adequate skilled health care professionals. This will 
include the unfreezing of all the frozen posts including structural review and 
adjustments of the clinics and the hospitals (Durban AIDS Conference 2016). 
 
5.5 Suggestions for Further Research 
This was a qualitative explorative research and based on what the researcher 
uncovered during the study, it is suggested that more research should be conducted 
including but not limited to the following: 
 Systematic investigation of the effectiveness of the current HIV and AIDS 
programmes in Public Health Care Facilities. 
 Study aimed at establishing the number of patients who have defaulted and who 
are no longer taking antiretroviral treatment in public health care facilities. 
 Research exploring the socio-economic impact of HIV and AIDS on fragmented 
family structures. 
 Research aimed at exploring the impact of HIV on patients who got infected 
through Mother-to-Child transmission. 
 Similar study is suggested at a larger scale that includes all health care facilities 
of the Gert-Sibande Region. 
 
5.6 Recommendations for Policy and Practice 
The researcher has the following recommendations for policy and practice: 
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 The current updates of the HIV policy which allows ARV treatment for all South 
Africans who tested positive regardless of their CD4 count should be 
implemented and maintained. 
 The provisioning of Pre-exposure prophylaxis (PrEP) should be implemented to 
enable those who are negative to remain negative. 
 
5.7 Conclusion 
This Chapter outlined major conclusions and the recommendations based on the 
empirical findings of the study. The objectivity of the researcher is reflected throughout 
this study. 
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APPENDICES 
APPENDIX A   
PARTICIPANT INFORMATION LEAFLET  
TITLE OF THE STUDY: Exploring accessibility of antiretroviral treatment amongst 
people living with HIV and AIDS at Public Health Care facilities in Gert –Sibande Region 
in Mpumalanga. 
Researcher: M.O Mohale 
Student Number: 31498728 
Supervisor: DR.T.R Netangaheni: 076 841 0983 /076 189 5087 
Good day 
1. You are invited to take part in a research study. The researcher (M.O Mohale) will 
avail himself for any enquiries regarding the study. 
2. The purpose of the study is to explore the accessibility of antiretroviral treatment 
amongst people living with HIV and AIDS in Gert-Sibande Public Health Care facilities 
in Mpumalanga. 
3. The researcher will ask you some questions and with your permission record and 
write down the answers. There will also be follow-up questions during the interviews. 
4. The University of South Africa had granted the research ethical approval, which 
means the study will comply with the code of ethics of scientific research on human 
participants. 
5. Participants have the right to full decision making, right to full disclosure, informed 
consent, right to privacy, referrals and the participants have a right to discontinue with 
the study at any given time without penalty. You will not be prejudiced or forced in 
carrying on with the study. 
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6. The study will not pose any physical harm and or discomfort to the participants and 
anything that may pose threat or risk shall be eliminated .The nature of this study is 
such that no physical harm is anticipated whatsoever. 
7. There is no direct reward in participating in the study; the reward is indirect as the 
results of the study might be used to improve the situation in public health care facilities 
in Gert-Sibande region. 
8. The information collected from the study will be treated with strict confidentiality. No 
participant„s information shall be disclosed to any one and such information shall be 
treated with great confidentiality. 
 
Researcher: M.O Mohale           : Mobile Number: 0790763307 / 0735086706 
Supervisor: Dr T.R Netangaheni: Mobile Number: 076 841 0983 
Chairperson of the Health Sciences Ethics Committee:  
Prof L. Roets email: Roetshjl@unisa.ac.za 
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APPENDIX B 
 
INFORMED CONSENT 
I hereby confirm that I have been informed by the researcher, Mr. M.O Mohale about 
the nature, conduct benefits and the risks of the study. I have received, read and 
understood the participant information leaflet regarding the study. 
I am aware that the results of the study including my personal details will be 
anonymously processed in the study report. 
I may, at any stage without prejudice, withdraw my consent and participation in this 
study. I have had sufficient opportunity to ask questions and (of my own free will) 
declare myself prepared to participate in this study. 
 
Participant‟s name………………………………………………Date……………………… 
Participant‟s signature………………………………………… Date………………….…… 
Researcher‟s signature…………………………………………Date………………..…….. 
Witness‟s signature…………………………………………....  .Date……………………… 
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Clearance Certificate 
Accessibility of antiretroviral treatment has been a major problem and it has been 
ignored for quite some time now. Mr. M.O Mohale, student number 31498728 is a 
masters student at the University of South Africa whose title: Exploring the accessibility 
of antiretroviral treatment amongst people living with HIV in Gert-Sibande Public Health 
Care facilities In Mpumalanga has been approved by the research Ethics Committee in 
the Sociology Department. Please allow him an opportunity to undertake research at 
your institution or organization. Your assistance in responding to the questions asked 
will be appreciated. Be assured that this investigation will be conducted ethically until 
the study is concluded. Anonymity, privacy and confidentiality, among other ethical 
considerations will be fulfilled. Please remember that you may withdraw whenever you 
feel uncomfortable during the course of the investigation. 
............................................................................................................................................ 
 
I………………………………………………………………………………..undertake to 
participate in this research project and assure the researcher of my cooperation. This is 
also meant to confirm that I have been informed of all my rights as a research 
respondent. I am willing to participate in this investigation. 
 
Subject‟s signature ………………………………………………… 
Name………………………………………………………………… 
Date……………………………… 
Time……………………………… 
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APPENDIX C 
 
INTERVIEW GUIDE OF PARTICIPANTS IN WELLNESS PROGRAM IN GERT- 
SIBANDE REGION 
 
SECTION A 
 
BACKGROUND INFORMATION 
This section of the interview guide refers to the background or biographical information 
will allow us to compare groups of participants. 
Once again, you are assured that your response will remain anonymous. Your 
cooperation is appreciated. The researcher will spend plus / minus 35 minutes with the 
participant during the interview. 
1. Gender…………………… 
 
2. Age……………………….. 
 
3. Ethnicity………………… 
 
4. What are the capabilities of Gert-Sibande public health care facilities in providing 
antiretroviral treatment? 
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Answer……………………………………………………………………………………………..
………………………………………………………………………………………………………
…………………………………………………………………………………………………….. 
 
5. What can be done to improve the accessibility of antiretroviral treatment in Gert-
Sibande public health care facilities? 
Answer……………………………………………………………………………………………..
..…………………………………………………………………………………………………….
…………………………………………………………………………………………………….. 
 
 
SECTION B 
 
This section explores your preferences with regard to access to antiretroviral treatment. 
 
1. What was the situation for the past three months in relation to the accessibility of 
antiretroviral treatment? 
Answer……………………………………………………………………………………………..
………………………………………………………………………………………………………
…………………………………………………………………………………………………….. 
2. What are your experiences in relation to antiretroviral medication when coming for    
treatment? 
Answer……………………………………………………………………………………………..
………………………………………………………………………………………………………
…………………………………………………………………………………………………….. 
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3. What is your overall experience about the accessibility of the antiretroviral treatment? 
Answer……………………………………………………………………………………………..
…..………………………………………………………………………………………………….
.……………………………………………………………………………………………………. 
4. How do you get affected by the availability and the non-availability of the antiretroviral 
treatment? 
………………………………………………………………………………………………………
………………………………………………………………………………………………………
…………………………………………………………………………………………………….. 
This is the end of the interview. 
Thank you for participating in the study your time is highly appreciated. 
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